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TRANSCRIPTIONAL REGULATION OF GLUCOSE-6-PHOSPHATE
DEHYDROGENASE (G6PDH) BY GLUCOSE
Pramod U. Thekkat, M.S.
Western Michigan University, 2007

In liver, insulin and glucose regulate the expression of important genes for lipid
and carbohydrate homeostasis. Studies on the effects of glucose and insulin, including
effects on cell signaling, are vital since deficiencies in glucose utilization in cells and/or
insulin secretion contribute to conditions like obesity and diabetes. In liver, the pentose
phosphate pathway is one of the primary pathways that can utilize the excess
carbohydrate. Glucose-6-phosphate dehydrogenase (G6PDH) is an important rate limiting
enzyme in this pathway. Our laboratory has shown that both insulin and glucose induce
the expression of G6PDH, although the mechanism by which this transcriptional
regulation occurs is still not clear.
The transcriptional regulation by glucose on enzymes involved in carbohydrate
and fatty acid metabolism like glucokinase and fatty acid synthase involves transcription
factors that bind to specific sequences in the promoter regions within these genes.
Building on our previous findings and on the wealth of information reported for other
lipogenic genes, the aim of the present study is to determine the identity of transcription
factors that are utilized in the carbohydrate regulation of G6PDH gene expression in liver
cells in culture.
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CHAPTER I

INTRODUCTION

Central dogma of molecular biology

The paradigm of molecular biology is the central dogma. This hypothesis was
described by Watson and Crick in 1958. Watson and Crick were the first to determine the
true crystalline. structure of deoxyribonucleic acid (DNA), using model building and the
information derived from X-ray crystallography. After determining the DNA structure,
the mechanism of flow of information and its function were also determined. DNA is
paired nucleic acid molecules which form a double helix structure. The two strands of the
double helical DNA are comprised of nucleotides in one strand opposite to the direction
of the other strand. The two strands are held together by hydrogen bonds between the
nucleotide bases and the four types of bases present in DNA are adenine (A), thymine
(T), cytosine (C) and guanine (G). The hydrogen bonding between the two strands in a
DNA molecule is between bases A ._.. T and G .._. C. Thus the entire nucleotide
sequence of each strand of DNA is complementary to that of the other. The information
contained by the DNA strand is necessary to construct other components of the cell, such
as RNA and proteins. The genetic information carried by the DNA helps in the
development and control of processes both. at the cellular level as well as the whole
organism. The segments of DNA that carry this genetic information are called genes.
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Overall the flow of genetic information follows as: DNA + RNA + protein. In
order to read the information contained in DNA, genes are transcribed during
transcription into messenger ribonucleic acid (mRNA) (Figure 1). mRNA molecules
serve as templates for protein synthesis. The major differences between DNA and RNA

INFORMATION
STORAGE

INFORMATION
MESSENGER
mRNA

Protein

Figure 1: Central dogma of molecular biology.

is the sugar moiety of the molecules, with 2-deoxyribose of the DNA being replaced by
the pentose sugar ribose in RNA. Also the nucleotide base thymine in DNA is replaced
by uracil (U) in RNA. Protein is synthesized from mRNA by translation (Figure 1).
Translation is a process where genetic information is translated from nucleic acid to -an
2

amino acid. This process talces place on the ribosome and also requires transfer RNA
(tRNA). Each protein synthesized from mRNA has a unique function and may serve a

vital role in the regulation of physiological events in cells, tissues or organs.

Regulation of gene expression
Almost all eukaryotic genes contain a basic structure consisting of the transcribed
region (coding exons, non-coding introns) and a promoter region. Part of the promoter
contains a core region, the site to which RNA polymerase binds and forms a complex in
order to begin the process of transcription, the decoding of DNA sequence into
messenger RNA. Within the promoter region there are regulatory sequences known as
response elements which can bind various proteins called transcription factors (Figure 2).
Transcription factors can also interact with other transcription factor proteins. Binding of
the transcription factor to the regulatory sequences in the promoter can result in
activation or repression of gene transcription (messenger RNA synthesis). Thus
interaction of these proteins in the promoter directly or indirectly with the core promoter
complex, results in the regulation of the rate of gene transcription. The association of the
proteins within the promoter is aided by protein-protein interaction between the DNA
bound proteins and protein induced DNA bending (Lin, 1999). This unique interaction
among a number of transcription factors ensures that a gene is transcribed at a proper
time and in a particular cell type. Regulation of transcription factor amount and activity
can thus regulate gene expression (Wolberger, 1999).
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Figure 2: Regulation of gene expression.

Lipogenesis in liver
Carbohydrates can be a major part of the diet and upon uptake by tissues or
organs, are immediately either converted into energy, stored as glycogen, or converted
into fats. The total energy content of the diet must be balanced with the energy
requirements of the human body. If excess foods are ingested beyond the body's energy
needs, the excess foods are converted into fat. If insufficient calories are ingested, the
energy deficit is made up by oxidizing carbohydrate and fat reserves.
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Figure 3: A simplified diagram of lipogenesis in the liver. Adapted from Towle et al.,
1997.

Lipid and carbohydrate metabolism is therefore in a constant state of dynamic
equilibrium. This means that some carbohydrate or lipids are constantly being oxidized to
meet energy needs, while others are being synthesized and stored. Long term storage
5

occurs primarily as lipid. In rats for example, the average life-time of a single lipid
molecule ranges from 2 to 10 days. A similar figure probably applies to human lipid
metabolism.
The sequence of reactions involved in the formation of lipids from glucose is
known as lipogenesis. The synthesis occurs in the cytoplasm in contrast to the
degradation (oxidation) which occurs in the mitochondria. Enzymes central to the process
• of lipogenesis are those that catalyze the degradation of glucose through glycolysis and
the subsequent synthesis of fatty acids through fatty acid synthase (FAS). Glycolysis
takes place within the cytosol of a cell and oxidizes glucose with 6 carbons to two
molecules of pyruvic acid. Besides the generation of high energy molecules like
adenosine triphosphate (ATP), glycolysis provides precursors for lipid synthesis. The
three main enzymes involved in fatty acid synthesis are ATP-citrate lyase, acetyl
coenzymeA carboxylase (ACC), and fatty acid synthase (Figure 3). ATP-citrate lyase
converts citrate to acetyl-CoA. ACC is the enzyme that catalyzes the conversion of
acetyl-CoA to malonyl-CoA (Figure 3). Fatty acid synthase utilizes acetyl-coA and
malonyl-coA to synthesize palmitic acid. In liver, the activity of these enzymes involved
in fatty acid synthesis are induced by a high carbohydrate diet (Foufelle et al., 1996). The
mRNA's encoding these enzymes are also induced by a high carbohydrate diet. Fasted
and fasted/refed studies on liver of rats (for ACC, ATP-citrate lyase) and mouse (for FAS
studies) fed on high carbohydrate diets have shown that these enzymes activities and their
corresponding mRNA increased to 20 fold (FAS), 50 fold (ACC) and to over 100 fold
(ATP-citrate lyase) (Elshourbagy et al., 1990; Pape et al., 1988; Paulauskis and Sul,
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1989). Enzymes like glycerol-3-phosphate acyl transferase and steoryl-CoA desaturase
that are involved in triglyceride formation, are also induced by high carbohydrate diet
(Shin et al., 1991; Thiede and Strittmatter, 1985).
Increased lipogenesis is dependent on effective glycolysis. Important glycolytic
enzymes like glucokinase (GK) and pyruvate kinase (L-PK), which help regulate the flow
of important intermediates for metabolic pathways like the tricarboxylic acid cycle
(TCA) and fatty acid synthesis, are induced by high carbohydrate diet. The mRNA
induction of these glycolytic enzymes in livers of rats fed on high carbohydrate diet
increased upto 10 fold (lynedjian et al., 1987; Weber et al., 1984). Fatty acid synthesis
requires NADPH as a reducing potential. The major source of NADPH production is the
pentose phosphate pathway and through the reaction catalyzed by malic enzyme (ME)
(Figure 3). The pentose phosphate pathways key enzymes are glucose-6-phosphate
dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (6-PGDH).

The

mRNA encoding these key enzymes as well as that for malic enzyme are also shown to
be induced to 8 fold in livers of rats fed high carbohydrate diets (Dozin et al., 1986;
Miksicek and Towle, 1983; Prostko et al., 1989). Another important gene spot 14 (Sl4)
in rat liver is also induced on a high carbohydrate diet. This gene encodes for a protein
that plays a regulatory role in lipid metabolism (Liaw and Towle, 1984).
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Pentose phosphate pathway
The pentose phosphate pathway (PPP) also called the phosphogluconate pathway,
or hexose monophosphate shunt is primarily an anabolic pathway that utilizes excess
glucose present in the liver. The primary functions of this pathway are:
1. To generate reducing equivalents, in the form of NADPH, which is primarily necessary
for biosynthetic reactions including fatty acid metabolism.
2. To produce ribose-5-phosphate (R5P), that is necessary for the synthesis of
nucleotides, the building blocks of nucleic acids.
Nicotinamide adenine-dinucleotide (NAD+) and its reduced form NADH are
important cofactors that play vital roles as carriers of electrons in reduction potential
transfer in the cell. The reactions of fatty acid biosynthesis utilize large amounts of the
reduced form of nicotinamide adenine-dinucleotide phosphate (NADPH). As a result,
tissues that are high in fat synthesis such as the liver and adipose tissue have high levels
of the PPP enzymes. About 30% of the oxidation of glucose in the liver occurs via the
PPP. Also erythrocytes (red blood cells) utilize the reactions of the PPP to generate large
amounts of NADPH for reduction of glutathione, an antioxidant that protects cells from
free radicals. The conversion of ribonucleotides to deoxyribonucleotides through the
action of ribonucleotide reductase also requires NADPH as the electron source. Thus
rapidly growing cells also need large quantities of NADPH.
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The PPP reactions occur in the cytoplasm. This pathway has both oxidative
reaction steps as well as non-oxidative reaction steps. The oxidation steps occur at the
beginning of the pathway, utilizing glucose-6-phosphate (G6P) as the substrate. The
reactions catalyzed by glucose.:. 6-phosphate dehydrogenase (G6PDH), the key regulatory
enzyme of the pathway and 6-phosphogluconate dehydrogenase generate two moles of
NADPH for every mole of glucose-6-phosphate (G6P) that enters the pathway. The non
oxidative reactions of this pathway are reactions that generate ribose-5-phosphate. Other
non-oxidative reactions of the pentose phosphate pathway involve conversion of
nutritional 5 carbon sugars (ribulose-5-phosphate) into 6 carbon sugars (fructose-6phosphate) and 3 carbon sugars (glyceraldehyde-3-phosphate). Fructose-6-phosphate and
glyceraldehyde-3-phosphate are utilized by the glycolysis pathway to produce pyruvate.

Nutritional and hormonal regulation of metabolic genes
Glucose is obtained by hydrolysis of dietary carbohydrate within the small
intestine. Glucose, being a source of energy for cells in the body, is absorbed into the
blood stream and carried to different organs and tissues. A high concentration of glucose
in the blood stimulates the release of the hormone insulin from the beta cells of the
pancreas into the blood. The insulin then acts on certain cells in the body to stimulate
uptake, utilization or storage of glucose. Primary storage of glucose is in the form of
glycogen. The primary tissue for glycogen storage is liver. Thus the liver is an organ that
not only participates in the metabolism of carbohydrates but also plays a role in glycogen
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synthesis. If energy demand is low, the hormone insulin stimulates the liver to store
glucose in the form of glycogen and to promote the synthesis of fatty acids (lipogenesis).
The effects of nutrition and hormones on carbohydrate intake and fat biosynthesis
(lipogenesis) have been of great interest. Early studies on consequences of food intake in
rat liver were done in the late 1950's (Tepperman and Tepperman, 1958). These studies
used isotope tracer techniques to show that rat liver increased the fat production capacity
when the animals were fed or fasted/refed with carbohydrates. Studies with C 14 labeling
techniques showed the fate of extra cellular free glucose into intracellular phosphorylated
glucose (Renold et al., 1954). Following this, in 1960 Dipietro and Weinhouse examined
the enzymes involved in this process of conversion of glucose to a phosphorylated form
in rat liver and found hepatic glucokinase (Figure 3) as the enzyme responsible.
Glucokinase activity increased in liver extracts from rats fed with high carbohydrate diets
and decreased in fasted and diabetic rats (DiPietro and Weinhouse, 1960). These studies
utilized whole animals (in vivo) and correlated a direct cause and effect of a nutrient on
metabolic changes. The early methods to study the enzymes involved in metabolism were
limited to whole animal or analysis of enzyme activity in whole tissue. It was thus
difficult to study actual mechanisms involved in the regulation of metabolism in whole
animals. By the late 1960's and early 1970's, better methods to study metabolic events
were developed. This included the use of cells in culture and better bioassays for
determining the effect of nutrient on enzyme activity. The first nutritional studies in cell
culture were done in prenatal and postnatal chicks treated with glucose. In 1974
Goodridge et al. used this primary cell culture model to investigate the effect of high
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carbohydrate on the induction of various lipogenic enzymes such as fatty acid synthase
(Figure 3) and malic enzyme (Goodridge et al., 1974). The activities of these enzymes in
response to glucose were found to increase equally to the levels of newly hatched chicks
fed on high carbohydrate diet thus establishing primary cell culture as a viable model
system.
In the 1980's, enzyme synthesis/degradation was studied by methods using the
incorporation or loss of radiolabelled substrate or protein. This method showed that in
rats, fasted and refed with high carbohydrate diet, the enzyme activity of L-PK and the
rate of synthesis of L-PK in vivo both increased (Cladaras and Cottam, 1980). Methods to
directly study changes in mRNA levels of specific proteins were also developed. This
new technology allowed a direct snapshot of molecular events associated with changes in
gene transcription and translation. These methods were used to show that high
carbohydrate diet increased the mRNA levels of rat liver pyruvate kinase and this
increase correlated with its increase in enzyme activity and protein synthesis, suggesting
that carbohydrate regulation of this important metabolic enzyme be at the transcriptional
level (Cladaras and Cottom, 1980). Similar studies in rat primary cell culture showed that
FAS activity was increased by glucose and this increase was due to increased enzyme
synthesis (Giffhorn et al., 1986). By the late 1980's, it was discovered that glucose and
the hormone insulin where involved in some capacity in the regulation of the expression
of various glycolytic and lipogenic enzymes such as S14, L-PK, FAS, ME, acetyl-CoA
carboxylase, and glucose-6-phosphate dehydrogenase (G6PDH) (Goodridge, 1987;
Mariash et al., 1986; Pape et al., 1988; Prostko et al., 1989; Vaulont et al., 1986). For
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example, in rat liver, ME mRNA increased after refeeding the animals with high
carbohydrate accompanied by decreased mRNA degradation, with no apparent difference
in the rate of transcription of the gene. Contrary to this, in rat hepatocytes in culture, both
insulin and glucose are required for the increased rate of transcription for FAS, S14 and
ACC (Shih and Towle, 1992). While these discoveries indicated that for many of these
important metabolic enzymes, the rate of transcription was a key point of regulation, the
mechanism by which this took place was still unknown. To investigate the mechanism,
the genes for these metabolic enzymes needed to be isolated and sequenced. The
nucleotide sequences for some of the lipogenic genes like GK, L-PK, S14 and ME were
isolated and sequenced in the late 80's and others such as G6PDH, FAS, ACC were
isolated in the 90's (Andreone et al., 1989; Liaw and Towle, 1984; Lone et al., 1986;
Morioka et al., 1989; Rank et al., 1994).
Also in the 90s, specific response element sequences within the promoter region
of the genes of many metabolic enzymes were identified. As noted earlier, response
elements are sequences within the promoter of genes to which transcription factors bind
and this binding of transcription factors can control the level of expression. For example,
Shih et al. in 1992 defined the presence of a carbohydrate response element in the
promoter of S14 gene. This sequence was found to be necessary for high carbohydrate
induction of S14 in rat liver (Shih and Towle, 1992). The induction of L-PK as well as
ACC by carbohydrate also requires the presence of a carbohydrate response element in
the promoter region of its gene (Thompson and Towle, 1991). Rat S-14 gene promoter
was found to have two motifs CACGTG separated by 5 base pairs, similar to that found
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in L-PK response elements, necessary for glucose induction of the gene. (O'Callaghan et
al., 2001; Shih et al., 1995). The FAS gene was shown to contain an insulin response
element that is necessary for insulin induced changes in gene expression (Roder et al.,
1997). Thus it was shown that genes may contain insulin response elements (IRE) and/or
a carbohydrate response element (ChoRE)/glucose response element (GRE) within the
promoter of its genes necessary for insulin and/or glucose effects on expression. The
proteins or transcription factors that bind to these response sequences under glucose or
insulin induction remained, however until very recently, unknown.

Glucose regulation of gene transcription
These ChoRE's of ACC, L-PK, S14 and FAS contain the DNA sequence 5'
CANNTG-3' (where N = A, G, T or C) (Liu et al., 1993; O'Callaghan et al., 2001; Rufo et
al., 2001; Shih et al., 1995). These DNA motifs are called E-Boxes. The E-box sequences
for the different genes are shown in Table 1. The E-box sequences of S-14 and L-PK
have an inverted orientation while FAS and ACC have a direct orientation (see Table 1).
Studies by mutation of the E-box motifs have shown that these E-boxes are critical for
the glucose response of these genes. Recent studies have also identified possible
regulatory proteins or transcription factors that may be involved in this regulation.

Transcription factors involved in the regulation of glucose responsive genes
Upstream stimulatory factor (USF), sterol regulatory element binding proteins
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..
..
..

Gene

Positions

Sequence

Reference

RAT
L-PK
Rat
S14
Rat
FAS
Rat
ACC

-166

CACGGGGCACTCCCGTG

(Liu et al., 1993)

-1439

CACGTGGTGGCCCTGTG

(Shih et al., 1995)

-7210

CATGTGCCACAGGCGTG

(Rufo et al., 2001)

-122

CATGTGAAAACGTCGTG

(O'Callaghan et al., 2001)

+

..

+

+

+

Table 1: Carbohydrate response elements in important lipogenic genes. E-box
sequences are bolded. Arrows shows orientation of E-box. Adapted from
Foufelle et al., 2002.
(SREBP), stimulatory protein 1 (SPl) and/or carbohydrate response element binding
protein (ChREBP) are four transcription factors which may be involved in the glucose
regulation of important lipogenic genes (Koo et al., 2001). These transcription factors
may bind directly to the E-box region of the genes or to other sequences in the promoter,
inducing transcription. High carbohydrate diets have been shown to stimulate the binding
of the transcription factor SPl to the promoter region of the gene for ACC. The binding
of SPl alone, however, is not sufficient for carbohydrate induction of the gene and
SREBP is thought to be needed as well (Oh et al., 2003). SREBPs are basic helix-loop
helix/leucine zipper (bHLH/LZ) proteins whose expression in liver is decreased by
fasting and increased upon refeeding in rats. It has also been shown to bind directly to the
promoter of FAS and ACC genes in rat liver (Shimano et al., 1999) and shown to be
necessary for carbohydrate response of these genes (Koo and Towle, 2000; Magana et al.,
2000). USF is another transcription factor that is also characterized by bHLH/LZ domain
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and can be of two forms in rat liver, USFl and USF2. USFs have the capability to bind to
the carbohydrate response elements of glucose responsive genes (Kahn, 1997). However,
it has also been shown that the binding of USFs by electromobility shift assays is non
specific to these response sequences (Kahn, 1997; Kaytor et al., 1997). Also,
overexpression of dominant negative form of USFl in rat liver cells treated with low and
high glucose for 48 hours, failed to diminish the glucose response of S14 and L-PK
promoter. However, the decrease in glucose response of S14 and L-PK genes in cells
treated with dominant negative form of USF2 for several days indicate that this
transcription factor may play a supportive role in this process (Kaytor et al., 1997; Vallet
et al., 1997).
Over the past few years, carbohydrate response element binding protein
(ChREBP) has also been found to be a transcription factor that has a strong influence on
regulation of lipogenic enzyme gene expression by glucose (Ishii et al., 2004). It has been
found to bind to the carbohydrate response element (ChoRE) of the rat liver pyruvate
kinase gene promoter under high glucose diet. (Yamashita et al., 2001). In 2004,
Stoeckman et al. showed that ChREBP requires and functions as a dimer with max-like
protein (Mlx) for glucose induction of L-PK, S14 and ACC lipogenic enzyme genes
(Stoeckman et al., 2004). ChREBP is found in the cytoplasm at low glucose levels and
under high glucose conditions, the dephosphorylation of serine and threonine residues of
ChREBP helps in the nuclear translocation and DNA binding to genes encoding
carbohydrate response elements of lipogenic enzymes (Kawaguchi et al., 2001).
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While the studies completed thus far have given us some indication of possible
mechanisms by which metabolic genes are regulated by factors such as carbohydrate and
insulin, we are still a long way away from truly understanding the entire process. Every
gene for key enzymes in metabolic pathways needs to be investigated thoroughly to
completely understand the effect of diet and hormones on gene expression. The Stapleton
laboratory has, for a number of years, studied the regulation of the expression of the key
enzyme in the pentose phosphate pathway, G6PDH. While the regulation of G6PDH
expression by hormones and nutritional factors has been studied, little evidence to date
exists indicating whether or not G6PDH is regulated by glucose transcriptionally and if
so what potential proteins could be involved.

Studies on G6PDH
Using primary cell culture, the enzyme activity of G6PDH has been shown to be
increased by insulin in cells from fasted rats (Kurtz and Wells, 1981). In addition to
stimulating expression, high carbohydrate was also shown to increase the stability of its
mRNA (Prostko et al., 1989). Early studies in our lab using diabetic animals showed that
G6PDH expression was regulated by insulin (Berg et al., 1995). To begin to study the
mechanism by which insulin and/or carbohydrate regulates the expression of this gene,
we cloned the DNA sequence for the promoter region of the gene (Rank et al., 1994).
Using this promoter sequence cloned into a reporter gene, as well as by measuring
endogenous mRNA levels, we showed that G6PDH expression was regulated
transcriptionally by insulin (Wagle et al., 1998).
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To begin to investigate whether or not glucose is also involved in the
transcriptional regulation of G6PDH, our lab utilized primary rat hepatocytes transiently
transfected with a luciferase reporter construct containing 935 bp of the G6PDH promoter
and incubated the cells under various glucose concentrations. These studies indeed
showed upregulation of the G6PDH reporter construct by glucose. To examine regions of
the promoter that might be responsible for the increase in expression observed with
increased glucose concentration, reporter constructs containing smaller regions of the
G6PDH promoter were tested. The results showed that the reporter construct containing
635 bp of the G6PDH promoter also responds to both glucose and insulin and this
segment of the promoter contains an E-box motif similar to the E-box motifs found in rat
L-PK, rat S14 and rat ACC genes (5'-CANNTG-3' where N = A, G, T or C) (Liu et al.,
1993; O'Callaghan et al., 2001; Rufo et al., 2001; Shih et al., 1995). The E-box appears
necessary for the insulin and glucose responses as mutation studies_ on the E-box region
abolished the response of the reporter construct in rat liver cells in culture (Arkwright
Keeler, 2005). While an increase in expression of the reporter construct by glucose is
indicative that the endogenous gene would respond similarly, it is not proof and further
studies were needed to clarify the effects of glucose on the expression of endogenous
G6PDH expression.

Objectives of study
Thus, the objective of this study was to more clearly define if glucose regulated the
expression of G6PDH and identify potential transcription factors involved in this gene
17

regulation. Therefore, the hypothesis of this study is that glucose induces the expression
of G6PDH by the activation of specific transcription factors that interact with promoter
sequences within the gene. To test this hypothesis, (a) glucose induced increase in mRNA
levels of G6PDH were measured using quantitative reverse transcriptase polymerase
chain reaction (qRT PCR) (b) a transcriptional inhibitor, actinomycin D, was used to
confirm the observed effects of glucose on G6PDH mRNA was indeed transcriptional (c)
a translational inhibitor, cyclohexamide, was used to determine whether or not ongoing
protein synthesis is required for glucose effects on G6PDH mRNA (d) transcription
factors potentially responsible for the transcriptional regulation of G6PDH gene were
identified using 'transcription factor binding site computer based search programs like
TFsearch, Matlnspector and TESS (e) a chromatin immunoprecipitation assay (ChIP)
was used to determine whether or not an identified transcription factor binds to the
G6PDH promoter sequence.

Transcription
Factors

RNA

Polymerase
/

General
Transcription
Factors

Gene

Core
Promoter
mRNA SYNTHESIS

Figure 4: Objective of study.
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CHAPTER II

MATERIALS AND METHODS

Hepatocyte isolation and maintenance

Male Sprague-Dawley rats weighing approximately 150-170 grams were obtained
from Charles River, Portege, Ml. Rats were maintained on Lab diet 5001 standard rodent
chow. Animal protocols were approved by the WMU Institutional Animal Care and Use
Committee (IACUC). Prior to hepatocyte isolation, rats weighing 180-200 grams were
fasted (provided drinking water) for approximately 48 hours. Animals were anesthetized
with an injection of pentobarbital. Hepatocytes were isolated using the perfusion and
collagenase digestion method (Stapleton et al., 1993). The liver was excised and forced
through three layers of gauze over a beaker using the digestion solution, and then
centrifuged in 50 ml tubes at 4°C for 3 minutes at 50 xg. The supernatant was aspirated
and the cell pellet was suspended, washed and centrifuged twice with cold Waymouth's
MB 752/1 (Gibco, Grand Island, NY) medium containing bovine serum albumin (BSA).
After the final washing· the cell pellet obtained was gently resuspended in the medium.
Cell viability was determined using trypan blue exclusion. _Cells with greater than 8085% viability were plated on sterilized 60 mm collagen coated plates (Falcon-3002). The
cells were incubated in 4 ml medium containing bovine serum albumin at 37°C in an
incubator (5% CO2 and 95% air) for 4 hours. After an attachment period of 4 hours, the
media was aspirated and cells were washed with 1 ml BSA free Waymouth's MB 752/1
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media. After the wash, the cells were incubated in glucose free Dulbecco's Modified
Eagle Medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with 5 mM glucose at
37°C in an incubator (5% CO2 and 95% air) for 18 hours.

Cell treatment
Eighteen hours after cell attachment, the media was aspirated and the cells were
then treated -with media containing 5 mM or 30 mM glucose and when indicated,
incubated with 250 ng/ml (44 nM) of insulin for either 6, 12, or 18 hours. For studies
involving transcriptional inhibitors, cells were pretreated for 30 minutes with either 1
µg/ml, 2 µg/ml or 5 µg/ml actinomycin D (Act D) (Sigma) or 5 µg/ml or 20 µg/ml
cyclohexamide (Cyc) (Sigma), followed by a media change prior to the addition of 5
mM or 30 mM glucose media.

Cell processing
Treated cells were processed by removing the media and washing twice with cold
phosphate buffered saline (PBS) solution. TRizol reagent (1 ml for each 60 mm dish) was
added at room temperature to the treated plates and the cells were scraped from the plates
and the suspension was then collected in eppendorf tubes for total RNA isolation and
quantification. For chromatin immunoprecipitation (ChIP) assays, after adding
formaldehyde to the treated cells for fixation, cells were processed by removing media
and washing twice with ice cold PBS solution. Cells were then scraped from the plates
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using lX PBS solution (1 ml for each 60 mm dish with 5 µl of protease inhibitor cocktail
(Sigma)). The cell suspension was collected in eppendorf tubes for ChIP assay analysis.

RNA isolation
Total RNA was isolated using RNA isolation kits (TRizol reagent kit, Invitrogen)
according to manufacture's protocol with modifications as previously described (Chin-ju
et al., 2004). The cell suspension during processing was tipped at an angle and allowed to
sit for about 5 minutes. The processed cell suspension containing 1 ml of TRizol/60 mm
dish was passed through a pipet tip several times to break up cellular clumps. The cell
suspension was then incubated at room temperature for 5 minutes to dissociate
nucleoprotein complexes. Chloroform (0.2 ml per 1 ml TRizol) was then added to the cell
suspension and vigorously shaken for 15 seconds. After incubation for 3 minutes at room
temperature, the cell suspension was centrifuged for 15 minutes (13400 xg

@

4°C) using

an eppendorf micro centrifuge. Following centrifugation, the mixture separates into a
lower red, phenol-chloroform phase, an interphase, and a colorless upper aqueous phase.
RNA remains exclusively in the aqueous phase and is transferred to a fresh eppendorf
tube. The volume of aqueous phase is about 60% of the volume of TRizol used for cell
processing. RNA is precipitated from the aqueous 'phase by adding isopropyl alcohol (0.5
ml per 1.0 ml TRizol reagent used). After incubation at room temperature for 10 minutes,
total RNA containing samples are centrifuged for 10 minutes (13400 xg

@

4°C). The

RNA precipitate forms a gel-like pellet on the side and bottom of the eppendorf tube. The
RNA pellet was washed with absolute ethanol (500 µ1 per 1 ml TRizol/60 mm dish used)
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after removing the supernatant. The RNA pellet is again centrifuged (3300 xg

@

4°C) for

5 minutes. The supernatant is again carefully removed and the gel-like RNA pellet at the
bottom is dissolved in diethyl pyrocarbonate (DEPC) treated water (15 µl of DEPC water
per sample RNA pellet). RNA samples are then analyzed for the concentration and
quality.

Determination of RNA content and quality assessment
For quantization of the RNA isolated, a spectrophotometer was used and readings
taken at wavelengths of 260 nm and 280 nm. The reading at 260 nm allows for
calculation of the concentration of nucleic acid in the sample.
1 O.D. (optical density) at 260 nm for RNA molecules= 40 ng/ul of RNA
The reading at 280 nm gives the amount of protein in the sample. Pure preparations of
RNA have OD26o/OD2so values of 1.8 to 2.0. If there is contamination with protein or
phenol, the ratio will be significantly less than these values.
For quantification of sample, 2 µl of sample was diluted with 998 µl DEPC water,
so the dilution factor was 500 (1000 µl total volume/2 µl sample). The whole 1000 µl
was put in a spectrophotometer cuvette and the O.D readings were taken. The RNA
concentration read was then:
OD 260* 40 ng/µl * dilution factor
For example if you have an OD260 = 0.1000, then the concentration is:
0.1000 * 40 ng/µl * (1000/2)= 2000 ng/µl or 2 µg/µl
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Reverse transcriptase polymerase chain reaction (RT PCR)
Real time quantitative PCR (qRT PCR) was done using a two-step method. All
reagents for two step qRT PCR were purchased from Applied Biosystems, Inc. First
RNA was reverse transcribed into cDNA on a thermocycler (Eppendorf Master Cycler
gradient) using the taqman reverse transcription kit. Reverse transcription reactions were
performed in a total volume of 100 µl that contained 3 µg of mRNA, 10 mM dNTP's
with dUTP, Taqman optimized buffer components and lOX reverse transcriptase enzyme

RT reaction - Thermocycler condition
(Eppendorf Master Cycler gradient)

RT reaction - components/reaction
(Total volume= 100 µl)
(Lot#D08561, Applied Biosystems, Inc)
1. lOX Taqman buffer - 10 µl

1. Lid

T = 105°C

2. 25mM MgC12

- 22 µl

2.Incubation

T = 25°c (10 min)

3. Random hexamers

- 5 µl

3.RT reaction

T = 48°C (30 min)

4. lOmM dNTP

- 20 µl

4.RT inactivation T = 95°C (5 min)

5. RNase inhibitor

- 2 µl

5.HOLD 4°c

6. RT enzyme

- 2.5 µl

7. DEPC water

- 18.5 µl

8. RNA sample (3µg) - 20 µl

Table 2: Reverse transcriptase reaction - components and thermocycler conditions. T =
temperature in degree Celsius and time in brackets, min = minutes, s = seconds.
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mix containing multiscribe reverse transcriptase enzyme and RNase inhibitor. Reverse
transcriptase (RT) reactions were performed as shown in Table 2.
The second step included quantitative RT PCR performed on the ABI prism 7700
sequence detection system using Taqman Universal PCR Master Mix kit (Applied
Biosystems, Inc). A primer/probe set for the G6PDH gene was commercially obtained
from Applied Biosystems (Taqman Gene Expression Assays (RN00566576_ml)). RT
PCR reactions were performed as shown in Table 3.

RT PCR - components/reaction
(Total volume = 25 µl)
1. 2X Taqman Universal
- 12.5 µl
PCR mix
2. Primer/probe (G6PDH) - 1.25 µl
(RN00566576_ml,
Applied Biosystems)
3. DEPC water
8. cDNA sample (3 µg)

- 6.25 µl

RT PCR - Reaction conditions
(ABI Prism 7700)
1. Lid

T = 105°C

2.Activation

T = 95°C (10 min)

3.Denaturation

T = 95°C (15 s)

4.Annealing/
Elongation

T = 60°C (1 min)

- 5 µl
5. Step (3) and (4)

-

40 cycles

6. Hold 4°C

Table 3: RT PCR - components and reaction conditions. T = temperature in degree
Celsius and time in brackets, min = minutes, s = seconds.
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The results of RT PCR were expressed as a fold induction by normalizing the
mean of the two threshold cycle values from the treated hepatocyte samples (30 mM
Glucose DMEM) divided by the mean of the threshold cycle value of the untreated
hepatocyte samples (5 mM Glucose DMEM). All samples were analyzed in duplicates.

Chromatin immunoprecipitation assay (ChIP)
Glucose treated rat hepatocytes plated in 60 mm plates were fixed by adding
formaldehyde, 1 % final concentration, directly to the culture media and subsequently
incubated at room temperature for 10 minutes (RNA Pol II) and/or 37°C for 15 minutes
(ChREBP). Six 60 mm plates were used per treatment. Media was aspirated and then
cells were washed twice with lX PBS. The ·plates were then placed on ice until
processing was complete. The cells were processed and scraped using lX PBS containing
4.5 µl protease inhibitor (p8340; Sigma). One milliliter (1 ml) of lX PBS with protease
inhibitor was used for the six plates in one treatment group. After scraping the first plate
with 1 ml lX PBS containing protease inhibitor, the cell lysate was pipetted and
transferred to the second plate. Likewise, final cell lysate was collected from the sixth
plate and transferred to an eppendorf tube and was put on ice. Cells were pelleted (100
xg, 4 minutes@ 4°C) and resuspended in SDS lysis buffer (1% SDS, 10 mM EDTA, pH
8.0) (Upstate) with protease inhibitor (p8340; Sigma). The cell lysate collected from the
six plates per treatment were resuspended with 1 ml of SDS lysis buffer containing 4.5 µl
protease inhibitor and aliquoted into two tubes each containing 500 µl of sample. The
resuspended cell lys_ate was stored at -80°C or placed on ice for 10 minutes, if used
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immediately. If cell lysate stored at -80°C was used, the samples were thawed on ice
before sonicating. Fifty micro liters (50 µl) of the cell lysate was removed and stored in a
separate tube (unsonicated sample). The remaining cell lysate (450 µl) was sonicated
with a Fisher Scientific 50 Sonic Dismembrator at a power level 6, output 65%, with 10
second pulses for 8 times. Between each pulse, the cell lysate was placed on ice for about
15-20 seconds, as sonication generates heat that could damage cell components. After
sonication, cell debris was removed by centrifugation (9300 xg, 10 minutes

@

4°C) and

the supernatant was removed into new tubes (sonicated sample). Sonicated chromatin
was sometimes stored at -80°C. Three hundred micro liters (300 µl) of sonicated sample
was used for each immunoprecipitation (IP) reaction. The IP reaction was performed with
an EZ Upstate Chromatin Immunoprecipitation (EZ- ChlP) assay kit. The RNA
polymerase II antibody (anti-RNA pol II) (rabbit polyclonal antibody, 25 µg/60 µl) was
from Upstate (EZ ChIP kit). ChREBP antibody (rabbit polyclonal antibody (1 mg/ml),
#NB400-135) was from Novus Biologicals, Inc. Three hundred micro liters (300 µl) of
sonicated sample was diluted with 1600 µl of dilution buffer (Upstate). One hundred
micro liters (100 µl) of this diluted sample was withdrawn to a new eppendorf tube for
input DNA. The remaining 1500 µl of diluted solution was incubated with protein G
agarose beads (Upstate) for 30 minutes with rotation
centrifugation (100 xg, 1 minute

@

@

4°C and after a brief

4°C), the supernatant was incubated with antibody

(10 µl of anti-RNA polymerase II antibody from Upstate or 5 µl of anti-ChREBP
antibody from Novus Biologicals, Inc) at 4°C for 12 hours with rotation. Antibody
protein-DNA complex was incubated with protein G agarose beads for 1 hour

@

4°C

with rotation. Antibody-protein-DNA complex was pulled down with protein G agarose
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beads (centrifuge for 1 minute @100 xg, 4°C). This complex was washed sequentially
with low salt buffer containing 150 mM NaCl, high salt buffer containing 500 mM NaCl,
lithium washing buffer containing 0.25 M LiCl one time each and two times with Tris
EDTA buffer (pH 8.0). After each wash the complex was pulled down (centrifuge for 1
minute @100 xg, 4°C) and the wash was discarded. Protein-DNA was eluted from the
complex by adding 200 µl elution buffer (0.1 M NaHCO3, 1% SDS) at room temperature
(gently mix the elution buffer + complex initially) followed by an incubation for 15
minutes at room temperature. After centrifuging for 1 minute at 100 xg and 37°C, the
elute was collected in a fresh tube. Another 200 µl of elution buffer was added, the
elution step was repeated. A total of 400 µl of elute was collected (Pooled elute).
Unsonicated sample, input DNA, and the pooled elute (400 µl) which contains the
protein-DNA cross-linked was reverse cross linked by incubating with 5 mM NaCl at
65°C for 12 hours. After incubating, the reverse cross-linked protein-DNA sample was
incubated for 1 hour at 37°C after addition of 2 µl RNase (Upstate), proteins were
digested by proteinase K (Invitrogen) at 45°C for 2 hours. Unsonicated and sonicated
DNA samples are analyzed for shearing using a 4% agarose gel. DNA fragments of the
IP elute and input DNA were purified using purification spin columns from Upstate.
After mixing the sample (elute (400 µl) or input DNA (100 µl)) well with 1.5 ml of
binding reagent A (Upstate), 600 µl of sample was transferred to a spin filter column. The
sample was then centrifuged at 13400 xg at room temperature for 30 seconds. The
solution in the collection tube was discarded and the spin filter was retained. This step
was repeated until the entire sample was passed through the spin column. Five hundred
micro liters (500 µl) of wash reagent B (Upstate) was added to the spin column and
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centrifuged at 13400 xg at room temperature for 30 seconds. The solution and the
collection tube were discarded and the spin filter was placed in a new collection tube.
Fifty micro liters (50 µl) of elution buffer C (Upstate) was carefully added to the center
of the spin filter membrane and the sample was centrifuged at 13400 xg at room
temperature for 30 seconds. The elute collected in the collection tube was the purified
DNA. The purified DNA sample (2 µl) was used as a template for the Polymerase Chain
Reaction (PCR). Primers for PCR amplification and conditions for the PCR reaction are
given in Table 4. The product (10 µl per well) was analyzed on a 4% agarose gel
electrophoresis for amplification.

PCR - Thermocycler condition
(Eppendorf Master Cycler gradient)

PCR reaction - components/reaction
(Total volume=50 µl)
(GoTaq Master Mix#M7122, Promega)
1. 2X GoTaq Green master Mix - 25 µl

1. Lid = 105°C

2. forward primer (100 ng/µl)

- 1 µl

2. Initial denaturation T = 95°C (2 min)

3. reverse primer (100 ng/µl)

- 1 µl

3. Denaturation

T = 95°C (30 s)

4. DNA template (<250 ng/µl)

- 2 µl

4. Annealing

T = 52°C (30 s)

5. nuclease free water

- 21 µl

5. Extension

T =12°c (30 s)

6. Cycles
7. Final extension

=32
T =72°C (4 min)

8.HOLD 4°C

Table 4: ChIP analysis - PCR components and thermocycler conditions. T =temperature
in degree Celsius and time in brackets, min =minutes, s =seconds.
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Statistical analysis
The results are presented as the mean +/-S.E.M. of n number of animals used in
the experiment. The comparisons within groups were performed by one-way analysis of
variance (ANOVA) followed by Student-Newman-Keuls test. Statistical significance was
tested at p<0.05.
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CHAPTER III

RESULTS

Effect of glucose on G6PDH mRNA production

To examine the effect of glucose on the production of G6PDH mRNA, liver cells
in culture were treated with different concentrations of glucose and times of incubation. If
glucose is involved in the transcriptional regulation of G6PDH, then the amount of
mRNA will change upon changing glucose concentration and this change can be
measured using qRT PCR. Liver cells in culture were treated with either 5 mM or 30 mM
glucose for various time periods (6 hours, 12 hours and 18 hours). Liver cells were then
processed and the amount of mRNA produced was measured using qRT PCR. The results
show that there is a significant increase in G6PDH mRNA levels with increased glucose
treatments. Glucose treatment of 30 mM for 6 hours showed a significant increase of 1.4
fold compared to 5 mM glucose treatment (Figure 5). After 18 hours of 30 mM glucose
treatment, the level of G6PDH mRNA showed a 2.5 fold significant increase compared to
the 5 mM glucose treatment (Figure 6). This indicates that the glucose induction of
G6PDH mRNA is both concentration and time dependent. The number of trials used for
the 12 hour study was not complete enough for statistical analysis and hence are not
included in these results.
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Figure 5: Effect of glucose on G6PDH mRNA increase at 6 hour treatment. Liver cells
in culture were treated and incubated with either 5 rnM or 30 rnM glucose for
6 hours. The cells were then processed and the G6PDH mRNA was measured
using qRT PCR. Fold changes were normalized to the mean of two threshold
cycle values and reported as percent control +/- S.E.M (n=8). Statistical
analysis was performed by student t-test. * = Significant stimulation
compared to 5 rnM glucose treatments (p<0.05).
Effect of glucose and insulin on G6PDH mRNA production
To examine the possibility that glucose and insulin induce a G6PDH mRNA
increase via separate mechanisms, the effect of the combination of insulin and glucose
was investigated. Additionally, since our lab has previously shown that insulin induces
the expression of endogenous G6PDH under high glucose conditions (Wagle et al., 1998)
this experiment can be used as a positive control for glucose induction of G6PDH
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mRNA. Liver· cells in culture were treated with different concentrations of glucose (5
mM or 30 mM) and or 250 ng/ml insulin for various time periods (6 hours and 18 hours).
Liver cells were then processed and the amount of G6PDH mRNA produced was
measured using qRT PCR. The results show that there is a significant increase in mRNA
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Figure 6: Effect of glucose on G6PDH mRNA increase at 18 hour treatment. Liver cells
in culture were treated and incubated with either 5 mM or 30 mM glucose for
18 hours. The cells were then processed and the G6PDH mRNA was
measured using qRT PCR. Fold changes were normalized to the mean of two
threshold cycle values and reported as percent control +/- S.E.M (n=8).
Statistical analysis was performed by student t-test. * = Significant
stimulation compared to 5 mM glucose treatments (p<0.05).
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levels with increased glucose and glucose + insulin treatments (Figure 7 and Figure 8).
Insulin treatment with 5 mM glucose compared to 5 mM glucose alone for 6 hours and 18
hours showed a significant increase of 1.8 fold and 3.1 fold, respectively. Similarly,
insulin with high glucose treatment (30 mM) also showed a significant increase of 1.85
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Figure 7: Effect of glucose and insulin on G6PDH mRNA increase at 6 hour treatment.
Liver cells in culture were treated and incubated with either 5 mM or 30 mM
glucose and if indicated, with 250 ng/ml insulin for 6 hours. The cells were
then processed and the G6PDH mRNA was measured using qRT PCR. Fold
changes were normalized to the mean of two threshold cycle values and
reported as percent control +/- S.E.M (n=8). Statistical analysis was
performed by ANOVA followed by Student-Newman-Keuls test. * =
Significant stimulation compared to 5 mM glucose treatments; Li= denotes a
significant difference from 30 mM glucose (p<0.05).

33

fold and 3.75 fold compared to the 5 mM glucose treatment alone (Figure 7 and Figure
8). Hence these result show a near additive increase in G6PDH mRNA levels when cells
are treated with glucose and insulin for 18 hour. This suggests that both glucose and
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Figure 8: Effect of glucose and insulin on G6PDH mRNA increase at 18 hour treatment.
Liver cells in culture were treated and incubated with either 5 mM or 30 mM
glucose and if indicated, with 250 ng/ml insulin for 18 hours. The cells were
then processed and the G6PDH mRNA was measured using qRT PCR. Fold
changes were normalized to the mean of two threshold cycle values and
reported as percent control +/- S.E.M (n=8). Statistical analysis was
performed by ANOVA followed by Student-Newman-Keuls test. * =
Significant stimulation compared to 5 mM glucose treatments; L\ = denotes a
significant difference from 30 mM glucose (p<0.05).
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insulin may induce G6PDH gene expression via separate mechanisms and correlate with
the results observed when using the reporter plasmid containing G6PDH promoter in
these studies (Arkwright-Keeler, 2005).

RNA quality assessment
Extracted total RNA (T-RNA) used for qRT PCR must not contain contaminants like
genomic DNA, proteins, salts and solvents. To check the quality of the T-RNA extracted
and to check whether the extracted RNA is not decayed, quality control of the RNA was
performed by agarose gel electrophoresis and optical density measurements. Optical
density measurements are obtained to check the RNA yield and contamination with
proteins and salts. Concentrations of RNA through optical density measurements are
calculated as described in Materials and Methods. Ten micro grams (10 µg) of RNA in
DEPC water with 2 µl of RNA loading dye (total volume = 20 µl) was loaded onto a 1%
agarose gel. After electrophoresis for 1 hour and 10 minutes at 90 volts, the gel was
stained with 10 mg/ml ethidium bromide for 15 minutes. The stained gel was scanned
and the picture of a representative blot is shown (Figure 9). The presence of genomic
DNA will be visible as a tight DNA band of high molecular weight (close to the loading
well). The mRNA decay is inferred from the quality of rRNA (ribosomal RNA) bands
(lanes 4, 5, 6 in Figure 9) and the presence of low molecular weight smearing (if present,
below rRNA bands).
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Figure 9: RNA quality assessment. Ten micro grams (10 µg) of RNA was loaded into
each well (lanes 1-9) in a 1% agarose gel. The gel was electrophoresised for 1
hour and 10 minutes at 90 volts. After gel staining for 15 minutes with 10
mg/ml ethidium bromide, the stained gel was scanned and the picture of a
representative blot is shown.
Effect of a transcriptional inhibitor on G6PDH mRNA production
To elucidate whether the effect of glucose on the increase in G6PDH mRNA was
indeed transcriptional, the effect of a transcriptional inhibitor on this increase was
studied. The transcriptional inhibitor, actinomycin D (Act D) inhibits the transcriptional
process by intercalating between the DNA molecules resulting in the basal transcription
complex comprising of the RNA polymerase and other proteins not recognizing the DNA
sequence and hence inhibiting mRNA synthesis (Perry et al., 1970). For thes�
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experiments, liver cells in culture were pretreated with actinomycin D (Act D) for 1 hour.
Various concentrations of Act D were used (1 µg/ml, 2 µg/ml and 5 µg/ml). After
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Figure 10: Effect of a transcriptional inhibitor on glucose induction of G6PDH mRNA.
Liver cells in culture were pretreated with Actinomycin D (Act D - 1 µg/ml,
2 µg/ml or 5 µg/ml where indicated) for 1 hour. After a media change, the
cells were incubated with either 5 mM or 30 mM glucose for 18 hours. The
cells were then processed and the G6PDH mRNA was measured using qRT
PCR. Fold changes were normalized to the mean of two threshold cycle
values and reported as percent control +/- S.E.M (n=3). Statistical analysis
was performed by ANOVA followed by Student-Newman-Keuls test. * =
Significant difference compared to 5 mM glucose treatments;�= denotes a
significant difference from 30 mM glucose (p<0.05).
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preincubation, the media was removed from the plates and cells were then treated with
different glucose concentrations (5 mM and 30 mM) for 18 hours. Cells were then
processed and the amount of G6PDH mRNA produced was measured using qRT PCR.
Results show that in the presence of Act D, basal levels of G6PDH mRNA at 5 mM
glucose were decreased (Figure 10) suggesting that on-going transcription is necessary to
maintain a basal level. Similarly, incubation of cells with Act D showed no increase in
G6PDH mRNA with 30 mM glucose and indeed the levels of mRNA paralleled the levels
observed with 5 mM glucose and Act D suggesting that transcription is indeed needed for
the increase in G6PDH mRNA expression by glucose.

Effect of a translational inhibitor on glucose mediated up-regulation of G6PDH
To better understand the mechanism by which glucose upregulates the expression
of the G6PDH gene, liver cells in culture were pretreated with, a protein synthesis
inhibitor, cyclohexamide. Cyclohexamide effects protein synthesis by interfering with
peptidly transferase activity, thus blocking translational elongation (Munro et al., 1969).
For this study, liver cells in culture were pretreated with cyclohexamide (Cyc) for 1 hour.
Different concentrations were used for pretreatment (5 µg/ml or 20 µg/ml). After this,
media was removed from the plates and cells were treated with different glucose
concentrations (5 mM and 30 mM) for 18 hours. Cells were then processed and the
G6PDH mRNA produced was measured using qRT PCR. Results show that in the
presence of cyclohexamide, basal levels of G6PDH mRNA at 5 mM glucose were
slightly elevated (Figure 11) but were not significant with n = 3 (n = number of rats used
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Effect of a translational inhibitor on glucose mediated upregulation of
G6PDH mRNA. Liver cells in culture were pretreated with cyclohexamide
(Cyc - 5 µg/ml, 20 µg/ml where indicated) for 1 hour. After a media
change, the cells were incubated with either 5 mM or 30 mM glucose for
18 hours. The cells were then processed and the G6PDH mRNA was
measured using qRT PCR. Fold changes were normalized to the mean of
two threshold cycle values and reported as percent control +/- S.E.M
(n=3). Statistical analysis was performed by ANOV A followed by
Student-Newman-Keuls test. *=Significant difference compared to 5 mM
glucose treatment; � = denotes a significant difference from 30 mM
glucose (p<0.05).

for this experiment). On the contrary, incubation of cells with cyclohexamide showed no
increase in G6PDH mRNA with 30 mM glucose suggesting that addition of this inhibitor
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blocked the induction of glucose mediated up-regulation of G6PDH gene (Figure 7) and
that this increase in the expression of G6PDH by glucose requires ongoing protein
synthesis.

The glucose-6-phosphate dehydrogenase promoter sequence:
Database analysis for putative transcription factor binding sites
A part of the promoter sequence of the G6PDH gene was isolated, cloned and sequenced
by Rank et al. in 1994. The 935 base pair (hp) promoter sequence which contains an E
box region is shown in Figure 12. This sequence was analyzed for putative transcription
factor (TF) binding sites. The putative TF binding sites within this promoter were
identified using three separate databases. Matlnspector (Cartharius et al., 2005), TF
Search (Kolchanov et al., 1999) and Transcription Element Search System (TESS)
(Marinescu et al., 2005) were employed. These putative binding site identifier programs,
searches large library of proteins available through databases to give a list of putative
proteins that are capable of binding to the sequence of interest (Appendix A). By
providing certain parameters like species of interest and estimated binding affinity of the
protein to the DNA sequence of interest, the search result can be limited and a list of 200150 putative transcription factors from each programs, that are capable of binding to rat
G6PDH promoter is listed in Appendix A. The approach utilized to narrow down the
number of putative TF by relevance to gene and protein function is shown in Table 5.
Based on results from the approach used and extensive literature study, putative TFs that
may influence glucose expression of G6PDH are listed in Figure 13.
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-878 ccagaagtga agagggcagg agcagcggca gaatcggagc tcctaggaaa
-828 tcctagtcag gcggtcaccc ttcccttctc agcagtggaa aaccccactt

-777 cggcttccgg tgtcgtaagt gtgggatccg gaagtaaaac acagactcaa
-728 aggcattaat actagagagt taaaactccg aagtgccaca ctctgctcca

-678 aagtcttaga ccgccagcct gcgttggcca gcggaacagc agaatgctcc

-628 ttactgataa acatcacaac tcttatacac acaatttttt ttttggacag
ChREBP
-BOX --.,
1-578 ggtcctacgt agaccagact agcctcggac tcagagat c acctgccttt :
-528 ltttccgt�����taa agcagtgagt caccatg�;c-a�{cTc���- I
SREBP
SREBP
-478 tcaccccatt t aaggcat cgcatcctca ctaaaacacc cctggctctc

L

-428 tgctgccagg cccctactaa gttaaaagtc tagaggaagc tgcgaaactt
HIF
-378 gggccccaga agccaaacta gcctcaggaa gg gtggcta cgtgctaa g

-328 gaagtggggt catccgggaa ggtgcagggc cttgggggca gcggaaagct
-278 agaccataca ttatggctgg ggagactaag ggaatacagg agaactgagt

LnS�AAT
caagc aagacatcgc gatcgcggca ggggcatcag
-228 ggagctgce::f
-178 ggacggccaa aggcggagtt cgcgggattg cgcgcgcatt tatctctact

-128 cttctccccc ccctcctccc ccgcactgat agagtagccc gac"�t��
�
SPl
-78
ctgcct ctcctgagcg gggtcagctc agtcaaagca cacgccctct
+1
-28 tgcgttaaat gggccaacga agcttagccc ccggaaacgc tgtgcactac

+23 agatctgtga acgtgtttgg cagcggcaac taaat
Figure 12:

Rat G6PDH promoter sequence. The 935 bp
G6PDH promoter sequence with the transcription
start site denoted by+1. Adapted from Rank et al.,
1994 and Arkwright-Keeler, 2005.
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935bp G6PDH
Promoter Sequence
Transcription Factor (TF}
Binding Site Search
Proiams

t-llmber of FilteredTFs
Selected TFs Based Literature Review
j(1i and Relevance to
Putaf1ve TF s (Hght %Bindng)
.
on Set Parameters - Present Study

MA Tlnspector -.

500 __. 200

TFsearch

-. 450-. 150

TESS

-. 325 -. 125

�

/�

SREBP

50 _. 5

SP1

CCAAT
HIF

ChREBP

* Filtering based on> 90% complement"Y binding sequence for species of irterest jrodert)
kk Fi lteri based on recurri hi h % bind TFs from all 3 ro ams

Table 5: Summary for selection of putative transcription factor binding on G6PDH
promoter.
ChIP analysis for identification of transcription factor that bind the G6PDH promoter
Chromatin immunoprecipitation assay (ChIP) is a new robust experimental method used
to determine transcription factors that bind to specific regions on a DNA in living cells.
The main principle of this assay is that DNA bound proteins/transcription factors can be
fixed with formaldehyde to crosslink proteins to the DNA. After sonication of the
complex, the chromatin is harvested from the cells and subjected to _a immunoselection
process using specific antibodies to transcription factors. The DNA sequence cross-linked
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•

Database comparison of each
programs

•

Selective grouping of high
percentage putative binding of
TFs

•

Literature study of selected
putative TF

•

Literature review of TFs vs.
importance of present study

935 bp G6PDH
Promoter sequence

l

•

Matlnspector

•

TFsearch

•

TESS

1

•

Hypoxia Inducible
Factor (HIF)

-

Mediate insulin effect in
Glucokinase gene
(Ulrike et al., 2004)

•

CCAAT Binding Factor

-

•

Carbohydrate
Response Element
Binding Protein
(ChREBP)

Binds to FAS insulin response
element in rat hepatoma cell
(Roder et al., 2000)

-

Key regulator of glucose
metabolism in rat liver
(Dentin et al., 2004)

•

Sterol Regulatory
Element Binding Protein
(SREBP)

-

Stimulate insulin expression of
lipogenic enzymes in rat liver
(Seung et al., 2000)

•

Stimulatory Protein 1
(SP1)

-

Sp1 mediates insulin effect in Acetyl
CoA Carboxylase gene in rat liver
(Oh et al., 2003)

Figure 13: Approach to identifying putative transcription factor that may bind to
G6PDH promoter sequence.
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to the protein of interest will co-precipitate with the chromatin complex. After reverse.
crosslinking the protein bound DNA complex and purification of the DNA, detection of
specific DNA sequences is performed using PCR. An optimal condition for sonication of

A.

B.

Sonicated
DNA

i

Unsonica:ted
DNA

i

Figure 14: Optimization of DNA sonication. Ten micro liters (10 µl) of sonicated and
unsonicated DNA samples were loaded onto a 4% agarose gel. The gel was
electrophoresised for 1 hour and 40 minutes. After gel staining for 40
minutes with 40 ng/ml ethidium bromide, the stained gel was scanned and
the picture of the representative blot is shown.

cross-linked DNA to the desired base pair length is important for ChIP analysis.
Optimized sonicated product is important for effective binding of antibody to the protein
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of interest in the DNA-protein complex and robust amplication of PCR products.
Optimization depends on the cell type, concentration/lysis buffer and the equipment used
for sonication. Cross-linked DNA from rat liver cells in culture is sonicated as described
in Materials and Methods to obtain a population of 200 - 400 base pairs in length.
Unsonicated and sonicated samples are reverse cross-linked and protein digested as
described in Materials and Methods. Ten micro liters (10 µl) of this sample is mixed with
2 µl of DNA loading dye and electrophoresised in 4% agarose gel for 1 hour and 40
minutes at 90 volts. The ethidium bromide stained gel is scanned and the picture of a
representative blot is shown in B (Figure 14). DNA ladder used was Phi-X 174 RF DNA
Hae III digest (#07511, Promega) and is shown in A (Figure 14). As can been seen from
the gel, sonicated DNA appears as a smear since the high molecular weight DNA found
in the unsonicated lane is now fragmented into various sizes.
Carbohydrate Response Element Binding Protein (ChREBP) has been shown to
be an important transcription factor responsible for glucose induction of various lipogenic
genes in rat liver (Ishii et. al., 2004). Our lab, through mutation studies, showed that the
E-box region in the G6PDH promoter sequence is important for glucose induction of this
gene (Arkwright-Keeler, 2005). The computer analysis for putative transcription factors
showed ChREBP to be a good candidate to bind to the E-box region of the G6PDH
promoter. Chromatin immunoprecipitation assay (ChIP) was performed to test whether or
not ChREBP is bound to this region in the G6PDH promoter and whether or not this

45

A.

B.

Unspecified DNA

95 bpPCR
product

Figure 15: PCR product of ChIP analysis. Ten micro liters (10 µl) of PCR product
samples were loaded onto a 4% agarose gel. The gel was electrophoresised
for 1 hour and 40 minutes. After gel staining for 40 minutes with 40 ng/ml
ethidium bromide, the stained gel was scanned and the picture of the
representative blot is shown. 5 = 5 mM glucose, 30 = 30 mM glucose treated
samples.

binding differs with different glucose concentrations. Liver cells in culture were treated
either with 5 mM or 30 mM glucose for various time periods (6 hours, 12 hours, and 18
hours). Liver cells were then processed for ChIP assay as described in Materials and
Methods. Ten micro liters (10 µl) ofPCR amplified product was mixed with 2 µl of DNA
loading dye and electrophoresised in a 4% agarose gel for 1 hour and 40 minutes at 90
volts. The ethidium bromide stained gel was scanned and the picture of a representative
blot is shown in B (Figure 15). The DNA ladder used was Phi-X 174 RF DNA Hae III
digest (#G7511, Promega) and is shown in A (Figure 15). The 95 bp amplified DNA
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product that corresponds to the designed primers for the proposed binding site for
ChREBP and length of the product is shown for various time periods and glucose
treatments (5 mM·or 30 mM glucose) (Figure 15). Band density of the blot is represented
in a graph (Figure 16). The band densities were scanned and quantified by ImageJ
software program (ImageJ 1.37v, Java L5.0_09, National Institute of Health, USA). The
results show that ChREBP binding increases when the cells are incubated with the higher
30 mM concentration of glucose. These results also show that the increase in binding is
transient and maximal at 6 hour (Figure 16). Earlier time frames should be tested to ·
determine maximal i!1,duction of binding.
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Figure 16: ChIP assay to study ChREBP binding on G6PDH promoter. Liver cells in
culture were treated with glucose (5 mM and 30 mM) for· various time
periods as indicated. Cells were processed for ChIP assay as described in
Materials and Methods. The amplified DNA (PCR product) samples were
electrophoresed through a 4% agarose gel in lX TAE buffer and incubated
with ethidium bromide (40ng/ml) for 40 minutes. The stained gel was
scanned and the picture of the representative blot is shown in A. B. Band
density of the gel in a graph. Band densities were scanned and quantified by
lmageJ program and reported as percent control+/- S.E.M (n=3). Statistical
analysis was performed by student t-test. * = Significant difference
compared to 6 hour 5 mM glucose treatment. � = denotes a significant
difference from 18 hour 5 mM glucose (p<0.05).
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CHAPTER IV

DISCUSSION

Glucose is the major and preferred carbon and energy source of cells. Glucose
also plays a vital role in metabolism as a starting material for the biosynthesis of many
other major molecules and as a signaling molecule that regulates the physiology of a cell.
Most of the cells adapt their metabolism to avail themselves of this important carbon and
energy source. These adaptations of the cell often result in changes in gene expression
especially at the transcriptional level. In mammalian cells, improper use of glucose can
cause changes in gene expression resulting in obesity and type 2 diabetes.
Studies on glucose response and changes in gene transcription are best understood
m the yeast model, Saccharomyces cerevisiae, in particular molecular mechanisms
essential for metabolic responses to vario�s nutrients (Tatchell, 1986; Wills, 1990). In
yeast, as with other eukaryotic organisms, cellular macromolecules detect glucose levels
and initiate signal transduction within the cell. These signals result in changes in cell
metabolism and gene expression profiles. Current application of genomic and proteomic
approaches to the study of glucose signaling in yeast has provided us with detailed
information of the cells response to glucose. For example, after 20 minutes of glucose
exposure in S.cerevisae, changes in the expression level of approximately 25% of the
6000 genes occur by up to 3 fold (Wang et al., 2004). Some of the genes that are up
regulated by glucose include genes for RNA polymerase subunits, ribosomal RNA and
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transfer RNA processing enzymes, translation initiation factors, etc. Thus a major
transcriptional remodeling by glucose addition is directed towards enhancing
translational machinery. On the other hand, genes involved in oxidative respiration,
including components of the TCA cycle and all genes required for gluconeogenesis are
down-regulated significantly by glucose addition. Studies by Wang, et al in 2004, showed
that the transcriptional remodeling of the cell in response to glucose proceeds via the
Ras/Gpa2/cAMP/protein kinase dependent and independent pathway and Snf3/Rgt2/Yck
pathway (Wang et al., 2004). Until this study, it was thought that the majority of the
transcriptional remodeling under glucose addition was only via the induction of GTP
binding proteins like Rasl, Ras2 or Gpa2, members of the G-protein family (Thevelein
and de Winde, 1999). Ras proteins are monomeric G-proteins that switch between an
inactive GDP (guanosine diphosphate) bound state and the active GTP (guanosine
triphosphate) state. The switch from active to inactive form involves hydrolysis of bound
GTP by GTPases (a family of hydrolase enzymes) and inactive to active requires
replacement of GDP with GTP, accomplished by guanine nucleotide exchange factors
(GEF's). Gpa2 proteins are heterotrimeric and are composed of a,

p, y subunits. These

classes of G-proteins are, like the monomeric Ras proteins, capable of binding guanine
nucleotides. Both these classes of proteins play a role in the cell's adaptation to glucose
by regulating cyclic adenosine monophosphate (cAMP) levels. cAMP plays a vital role in
the cell's signal transduction, a process that mediates the effects of hormones or nutrients
by activating protein kinases. Ras and Gpa2 proteins regulate the cAMP levels in a cell
via different pathways (Gancedo, 1998). For example, Ras stimulation by the RasGEF's
in turn increases the production of cAMP levels by the essential product of adenylate
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cyclase gene (CYRl), Cyrl (a lyase enzyme) while Gpa2 proteins regulate cAMP levels
by associating with a protein Gprl, encoded by the gene GPRl, a member of the G
protein receptor family. Active protein kinases phosphorylate a number of proteins
involved in metabolism and transcriptional regulation in response to glucose. For
example, cAMP stimulated kinase Snfl, catalyses the phosphorylation of Migl, a
repressor of transcription for glucose transporters (Carlson, 1999; Gancedo, 1998). This
phosphorylation allows the transcription of genes for glucose transporters which are
otherwise repressed by Migl in the presence of low glucose or other sources of carbon.
The resulting signals can also up regulate activators like Cat8, for the transcription of
genes to produce enzymes involved in gluconeogenesis and down regulate activators like
Adrl, for the repression of genes involved in the utilization of other carbon sources.
S.cerevisae has a very unusual lifestyle in that it prefers to ferment glucose than
oxidize it, even in the presence of oxygen. Glucose oxidation proceeds via glycolysis to
pyruvate and the pyruvate. is converted to carbon dioxide and water (via TCA cycle),
generating up to 36 ATP's per molecule of glucose used. Only when oxygen availability
is limiting do cells ferment glucose since this process only results in two molecules of
ATP per molecule of glucose. Fermentation of glucose results in a high growth rate and
high respiratory quotient (CO2 production rate/O2 consumption rate) with low biomass
compared to glucose oxidation. In yeast, in the presence of high glucose, there exists
signaling pathways that induce enzymes to increase fermentation of glucose. These
pathways induce the expression of genes encoding enzymes of the glycolytic pathway
and proteins that help in glucose transport. For example, in the absence of glucose, Rgtl
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transcription factor binds to the promoter of a glucose transport gene like HXT and
represses its transcription. The Rgtl activity is modulated by proteins like Mthl and Stdl.
In the presence of glucose, Mthl and Stdl proteins are degraded resulting in the release
of the Rgtl repressor from the HXT gene and an increase in its expression. The signal
transduction that results in these events start at the cell.membrane with the help of two
glucose receptors Snf3 and Rgt2 that initiates the binding of glucose (Gelade et al.,
2003). The receptor activation induces a signal that activates a protein kinase Yck, which
is necessary for phosphorylation and degradation of Mthl and Stdl proteins (Moriya and
Johnston, 2004).
Yeast have evolved complicated and sophisticated mechanisms for sensing the
available glucose and utilizing it efficiently. In mammals, the importance of glucose
sensing is evident in their outstanding ability to maintain a constant level of glucose in
the bloodstream (5 mM), both during feeding and during periods of fasting. The
metabolic response to nutritional glucose in mammals is more complex than that in yeast
as it is a combination of affects with respect to glucose metabolism itself and the effects
of hormonal changes induced by the presence of glucose. The controlled glucose levels in
blood insure adequate supply of this energy source to glucose dependent tissues.
Regulation occurs by adapting to glucose levels obtained via nutrition and glucose
synthesis and this is accomplished to a large extent by balancing the glucose metabolism
by hormones such as insulin (produced in the pancreatic beta cells) and glucagon
(produced in the pancreatic alpha cells). Imbalance can lead to disease and severe
physiological consequences. Understanding how cells sense and respond to glucose is
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thus of great importance and significance. Secretion of insulin or glucagon when the
blood glucose levels are high and low, respectively, provides the main regulation of
glucose concentration in the body. The increase of insulin in response to high glucose
inhibits the expression of gluconeogenic enzymes like phosphoenolpyruvate carboxy
kinase (PEPCK). Gluconeogenesis is the biosynthesis of glucose from 3 carbon source
like pyruvate. The first step in gluconeogenesis involves the conversion of pyruvate to
phosphoenolpyruvate (PEP). This is accomplished by two enzymes, pyruvate carboxylase
and PEPCK. Pyruvate is carboxylated to oxaloacetate (OAA) by pyruvate carboxylase
and the OAA is then converted to PEP by PEPCK. Insulin also inhibits the activity of
glycogenolytic enzyme phosphorylase a (Aiston et al., 2003). Phosphorylase enzyme
takes part in the breakdown of glycogen and release of glucose to the blood. Insulin thus
inhibits the production of glucose synthesis and also glycogen breakdown and stimulates
the phophorylation, metabolism and storage of glucose (Pilkis and· Granner, 1992).
Glucagon is secreted by the alpha cells of the pancreas in response to low glucose and has
the opposite effects of insulin action, stimulating the synthesis of glucose as well as the
breakdown of glycogen (glycogenolysis) (Randal et al, ·1997). Glucagon has been shown
to bind to hepatic receptors linked to the cAMP (cyclic adenosine monophosphate)
second messenger pathway. cAMP therefore serves as the intracellular messenger for
glucagon (Pilkis and Granner, 1992) and has been shown to stimulate the expression of
gluconeogenic enzymes like PEPCK and inhibit the expression of glycolytic enzymes
like GK and L-PK (lynedjian et al., 1987; Vaulont et al., 1984). cAMP also inhibits
G6PDH of the pentose phosphate pathway and FAS and ACC of the fatty acid synthesis
pathway (Garcia and Holten, 1975; Towle et al., 1997).
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In beta cells, insulin production is coupled to glucose regulation and includes
transcriptional change in the gene encoding insulin. For this, transcriptional activators
like PDX-1, similar to the repressor protein Mig l in yeast, and Maf2 have been found to
be critical transcription factors that respond to the glucose concentration in beta cells.
Here, PDX-1 is phosphorylated under high glucose condition by kinases which result in
its nuclear translocation and along with Maf2 results in activation of the insulin gene
(Melloul et al., 2002).
Glucose entry into tissues is facilitated by glucose transporters. Some of the
important transporters are GLUT2 in liver and pancreatic beta cells and GLUT4 in
adipocytes and muscle (Olson and Pessin, 1996). GLUT2 and the glucose
phosphorylating enzyme glucokinase (GK) have a high Km for glucose. For GLUT2, a
high Km results in a high capacity for glucose transport which increases as a direct
proportionality of extracellular concentration of glucose. A high Km for GK establishes a
direct function between the plasma glucose concentration and the formation of glucose-6phosphate (G6P) (lynedjian et al., 1988). GLUT4 transporters and hexokinase
(Kolchanov et al.) in adipose tissue, have a low Km for glucose. The GLUT4 transporters
are translocated to the plasma membrane when insulin is present. When glucose enters, it
is phosphorylated by hexokinase. Should large concentration of G6P build up,
hexokinase is feedback inhibited by this compound (Olson and Pessin, 1996). After
phosphorylation by GK or HK, G6P can be utilized by glycolysis, the pentose phosphate
pathway or glycogen synthesis. The expressions of the genes encoding the key enzymes
of these pathways are stimulated by glucose and/or insulin (Girard et al., 1997). For many
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years, the effects of high carbohydrate on regulation were attributed to only the presence
of insulin (Horton et al., 2002; Osborne, 2000). Recent studies however, have shown that
glucose can directly regulate some of these metabolic enzymes involved in lipogenesis
(Towle and et al., 1997). For example, glucose increases the gene expression of L-PK,
ACC and FAS (Koo et al., 2001; Vaulont et al., 2000). Our lab has also shown that
glucose induces the expression of G6PDH (Arkwright et al. 2005). Studies like these
were necessary to begin to understand the mechanism underlying the control of the
expression of these genes by glucose. Studies utilizing cells in culture have resulted in
identifying regulatory sequences within the promoter sequences of these genes. Studies in
rat on the promoter sequences of the genes for acetyl-CoA carboxylase (Yechoor et al.),
L-pyruvate kinase (L-PK), S14 and fatty acid synthase (FAS) have found that they
contain regulatory sequences called carbohydrate response elements (ChoRE) (Liu et al.,
1993; O'Callaghan et al., 2001; Rufo et al., 2001; Shih et al., 1995). Further
investigations have also led researchers to identify transcription factors that may be
involved in the glucose control of the expression of these genes.
The earliest studies that investigated the effect of carbohydrate on G6PDH were
done on whole animals (fasted and refed). These studies by Prostko et al. showed that
glucose increased G6PDH gene transcription and also increased mRNA stability in rat
liver (Prostko et al., 1989). Using primary cell culture, G6PDH enzyme activity measured
by the production of· NADPH, showed an increase by insulin while glucose did not
influence the enzyme activity in cells taken from rats fasted from a carbohydrate diet
(Kurtz and Wells, 1981). Our lab has shown, using a reporter gene assay, that glucose
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regulates G6PDH expression in a concentration dependent manner (Arkwright-Keeler,
2005). The reporter gene contained 935bp of the promoter of G6PDH linked to the
reporter gene for luciferase. Studies by Hodge and Salati in 1997 showed that a post
transcriptional mechanism existed and also suggested that a change in the splicing of
mRNA transcript resulted in the regulation of G6PDH by glucose (Salati et al., 2004).
Recently the same group showed that the regulation of G6PDH mRNA splicing by
nutrients like glucose involves exonic splicing silencers (Olson and Pessin) in exon12 of
the G6PDH mRNA transcript (Szeszel-Fedorowicz et al., 2006).
The purpose of this study was to examine and better understand the mechanism
involved in glucose regulation of G6PDH, the rate limiting enzyme in the pentose
phosphate pathway. Evidence from our lab indicates that glucose regulation of G6PDH in
rat hepatocytes can occur at the transcriptional level while that of Salati indicates post
transcriptional. The disagreement in the mechanism of G6PDH regulation may be
because our lab studies as well as studies by Prostko were done in rat while Salati's
studies were done in mice. Salati's group also performed experiments in primary rat
hepatocytes to understand the mechanism of carbohydrate and insulin regulation of
G6PDH by measuring the G6PDH nuclear mRNA, and the transcriptional activity for
G6PDH activity. These studies suggested that transcriptional activity of the G6PDH gene
was unchanged in the nuclei of hepatocytes treated with glucose or insulin but increased
G6PDH mRNA upto 7 - 8 fold with insulin in high glucose conditions (Stabile, et al,
1998). These experiments were conducted for a time period of 24 hours in media
containing high glucose and therefore it is possible that a change in glucose mediated
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transcription was not detected because the cell's were exposed to high glucose during the
entire time of incubation. Our lab has previously shown that in rat hepatocytes incubated
in high glucose, insulin does increase G6PDH transcription and mRNA levels (Wagle et
al., 1998). Hence the current research was carried out to clarify these conflicting results
and to better understand the mechanism underlying glucose regulation of G6PDH.
In the present study, primary rat hepatocytes were maintained in low glucose
(5mM) for a period of 18 hours. After this incubation with normal physiological glucose
levels, cells were treated with low glucose (5mM) or high glucose (30mM) media
(hyperglycemic conditions) for various time periods. Under these conditions, our results
show a significant increase in G6PDH mRNA (1.4 fold) at 6 hours and a maximum
increase (2.4 fold) at 18 hours, illustrating a time dependent increase. These results also
support our labs previous findings on glucose induction of the G6PDH reporter gene
(Arkwright et al. 2005). In these studies reporter assays were utilized to assess the effect
of glucose on the G6PDH promoter activity. Glucose induction at high glucose
concentration was about two fold when the assays were conducted with 12-14 hours of
glucose treatment.
Insulin has been shown to induce mRNA levels of G6PDH in hepatocytes and this
effect was postulated to occur at the transcriptional level (Manos et al. 1991). Our lab
also showed, via reporter gene assay and northern blot analysis (for endogenous mRNA
measurement), that insulin together with high glucose induces the mRNA levels of
G6PDH in rat hepatocytes (Wagle et al., 1998). In order to verify these published results
using qRT PCR and to use insulin induction of G6PDH as a positive control for the
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proposed glucose studies, we included insulin treatments in these experiments. As
illustrated in Figure 7 and Figure 8, our results show that there was a significant induction
of G6PDH mRNA when insulin was added to both low and high glucose treatments.
Insulin treatment at both low and high glucose for 6 hour showed nearly a 1.8 fold
increase over baseline in G6PDH mRNA while insulin for 18 hour in low and high
glucose showed an increase of 3.1 and 3.75 fold respectively. Stabile et al. had shown
that a polyunsaturated fatty acid (arachidonic acid) inhibited the G6PDH mRNA increase
when hepatocytes were treated with high glucose together with insulin. Arachidonic acid
did not inhibit a change in G6PDH mRNA when treated with high glucose alone (Stabile
et al., 1998). These studies suggested that the polyunsaturated fatty acid inhibited insulin
signaling at a step below that which regulates glucose utilization or that insulin and
glucose operate via separate mechanism. Our lab studies measuring G6PDH promoter
activity through a reporter gene also suggested that glucose and insulin operated through
separate mechanisms as the combination was nearly additive. Our present results with
G6PDH mRNA increase with glucose and insulin support this conclusion.
To identify the mechanism by which glucose up regulates the G6PDH expression
and to clarify the conflicting results from Salati et al. suggesting that glucose induction of
G6PDH is only by a post transcriptional mechanism, we included experiments with a
transcriptional inhibitor, actinomycin D (Act D) and a protein synthesis inhibitor,
cyclohexamide. Actinomycin D has been shown to have an anti-cancer activity by
causing DNA damage and subsequent apoptosis of cells. Actinomycin D intercalates into
the DNA and this action immobilizes the RNA polymerase complex from synthesizing
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new RNA (Sobell, 1985). Studies utilizing actinomycin D to show transcriptional effects
are prevalent. In chick embryo hepatocytes in culture, the insulin induced FAS mRNA
increase was shown to be decreased in hepatocytes treated with actinomycin D (Wilson et
al., 1986). Keratinocyte growth factor (KGF), a potent and specific mitogen for epithelial ·
cells, interacts with a tyrosine kinase receptor (KGFR) to initiate signaling pathways that
result in rapid changes in the phosphorylation state of signaling proteins and transcription
factors, mediating the effect of KGF. Some of the effects of KGF include proliferation,
cell differentiation and lipogenesis. Chang, et al showed that in pulmonary epithelial cells
(H292 cells), actinomycin D inhibited the KGF induced activation of FAS and SREBP-lc
mRNA's (Chang et al., 2005) and concluded that the decrease in KGF induced mRNA
levels of FAS and SREBP are due to the transcriptional inhibition of gene expression.
Back et al. showed that the insulin and triidothyronine (a hormone secreted by the thyroid
gland, involved in controlling rate of metabolic processes in the body) induced ME
mRNA in chick embryo hepatocytes was inhibited by actinomycin D treated cells (Back
et al., 1986). These studies suggest that insulin and triidothyronine induced ME mRNA
increase is transcriptional. The use of a transcriptional inhibitor in our experiments
showed a decrease in tlie glucose induced µ6PDH mRNA at 5mM and 30mM glucose
treatments. This decrease in both low and high glucose level suggests that apart from a
post transcriptional mechanism suggested by Salati et al. there is indeed transcriptional
regulation of G6PDH by glucose.
In order to check whether ongoing protein synthesis is necessary for the induction
of gene expression, a protein synthesis inhibitor cyclohexamide isolated from
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Streptomyces griseus was used. Use of protein synthesis inhibitor provides a better

understanding of the mechanisms involved in the regulation and proteins involved in
gene expression. S.griseus is an antibiotic producing microorganism which produces
antibiotics like the streptomycin and cyclohexamide. These antibiotics were first shown
to inhibit protein synthesis in yeast (Kerridge et al. 1.958) and subsequently shown to
interfere with the activity of peptidyl transferease during translation elongation (Baliga et
al., 1969). Studies following inhibition of protein synthesis in yeast by cyclohexamide
showed similar effects in mammalian tissues including rat liver, mouse liver and human
lymphocytes (a type of white blood cell in the immune system) (Komer et al. 1966). KGF
induced activation of FAS and SREBP-lc mRNA's in epithelial cells, which was
inhibited by a transcriptional inhibitor, were also shown to be inhibited by
cyclohexamide. The transcriptional activation of FAS and SREBP in epithelial cells by
KGF thus requires ongoing protein synthesis (Chang et al., 2005). Xu et al. showed that
polyunsaturated fatty acids (PUFA) are involved in SREBP-lc mRNA decay in rat liver
cells. Addition of a protein synthesis inhibitor like cyclohexamide blocked the SREBP-lc
mRNA decay. These studies suggest that SREBP-lc mRNA translation is required for
mRNA decay and/or PUFA's may modulate the activity of the protein produced to
elevate SREBP-lc mRNA decay (Xu et al., 2001). Our experiments were conducted by
pretreating cells with cyclohexamide and measuring the mRNA increase. The results with
protein synthesis inhibitor showed that basal levels of G6PDH mRNA at low glucose
were slightly elevated but were not statistically significant. Results with cyclohexamide
and high glucose showed no increase in G6PDH mRNA suggesting that cyclohexamide
blocked the glucose induced increase and that this induction by high glucose
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concentrations requires ongoing protein synthesis. Enzyme activity and measurement of
the rate of enzyme synthesis studies of G6PDH with these inhibitors could be an
experiment that can be done to study whether or not a post translational mechanism is
involved in the regulation of G6PDH epzyme synthesis.
Studies investigating the regulation of lipogenic genes have been ongoing in an
attempt to uncover the mechanism by which this regulation occurs. Both insulin and
elevated glucose have been suggested to be initiating signals for this regulation. Koo et
al. have shown that both glucose and insulin induce S14 and L-PK lipogenic genes via
separate mechanisms in hepatocytes (Koo et al., 2001). This study showed that two
transcription factors, carbohydrate response factor (ChoRF) and sterol regulatory element
binding protein (SREBP) have two distinct DNA binding elements, ChoRE and SRE, in
the promoter of both S14 and L-PK genes. Studies utilizing both promoters in separate
reporter gene assays, showed that constructs containing the ChoRE were responsive to
glu�ose but not insulin directly while constructs with the SRE did not respond to glucose
but responded directly to insulin. Moreover, over expression of SREBP in these
experiments caused an insulin induction through SRE and not ChoRE. Studies on both
the L-PK and S-14 promoter, using reporter assays with the SRE binding site and with
vectors over expressing SREBP, did not show a difference in the reporter luciferase under
various glucose conditions, suggesting SRE to be non-responsive to glucose treatments
(Koo et al., 2001). Similar reporter assays showed that the transcriptional induction of
FAS and ACC by glucose and insulin require response elements, ChoRE and SRE
respectively, in the promoter region of their genes (Vaulont et al., 2000).
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In later studies, it was found that SREBP-lc, a highly expressed isoform of
SREBP in liver (Shimomura et al., 1997), is required for the insulin regulation of
lipogenic genes in liver (Yechoor et al., 2002),. SREBP-lc acts as a transcriptional
activator and together with other transcriptional activators like SPl and CCAAT binding
factors regulate the insulin responses of the ACC and. FAS promoters (Magana et al.,
2000; Sanchez et al., 1995). In liver, SREBP-lc is associated with regulating the process
of lipogenesis and the conversion of glucose to triglycerides for storage. Studies utilizing
SREBP-lc gene knockout mice, after a high carbohydrate diet, found that the insulin
induced mRNA of lipogenic genes like FAS and ACC showed decreased levels as
compared to wild-type mice (Liang et al., 2002). These studies further established
SREBP-lc as a factor mediating the insulin response under high carbohydrate diet.
Mutation studies utilizing a reporter gene and the S14 promoter (with mutated
ChoRE) showed that ChoRE was needed for the glucose but not the insulin response
(Koo and Towle, 2000). Stoeckman et al. suggested that direct glucose responses in FAS,
ACC and L-PK requires the activation of proteins called carbohydrate response factors
(Stoeckman et al., 2004), indicating that there are direct mediators of carbohydrate
induced lipogenic gene expression. Studies using affinity chromatography and mass
spectrometry on lipogenic genes like L-PK, ACC and FAS revealed the presence of a
basic helix-loop-helix/leucine zipper (bHLH/LZ) protein that was bound to the E-box
sequence in the promoter of these genes (Yamashita et al., 2001). In this study, nuclear
proteins from rat liver were isolated using DNA-affinity column chromatography and
analyzed by SDS-PAGE gel electrophoresis. The protein obtained was cleaved into
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peptides by proteases such as trypsin and the masses of the peptides were determined
using a mass _spectrometry and genome analysis was done on various computer programs.
This led to the recently discovered 100 k-Da bHLH/LZ protein which was named
carbohydrate response element binding protein (ChREBP) (Yamashita et al., 2001). This
protein binds the ChoRE of the L-PK gene and the binding site is comprised of two 6 bp
motifs (CACGTG) called E-boxes separated by a 5 bp sequence (Shih et al., 1995). It has
been shown through reporter gene assays containing mutated E-box sequences, that both
E-boxes are necessary for the glucose response of L-PK. The promoter region of ACC,
FAS and S14 genes also contain a similar E-box motif (two E-boxes separated by 5 bp).
The mRNA of ACC, FAS and L-PK decreased considerably with ChREBP gene knock
out mice fed with high carbohydrates compared to wild-type, indicating that it is a very
important factor for glucose induction of these genes as well (Ishii et al., 2004).
Since our results, using qRT PCR, showed that G6PDH mRNA increases under
high glucose treatments and the studies with inhibitors showed that this induction was
most likely transcriptional, it was of interest to study the involvement of transcription
factors, especially ChREBP in this glucose induced transcriptional increase of this gene.
Our lab had shown that the G6PDH promoter has an E-box with an imperfect sequence
(CACCTG) and in reporter assays, mutation of this E-box region showed that it is indeed
necessary for the glucose response of the G6PDH gene (Arkwright-Keeler, 2005). The
analysis of transcription factor databases yielded a high likelihood that ChREBP was a
good candidate to bind to the E-box region of G6PDH, thus we set out to determine the
ability of ChREBP to bind to this region of the promoter. Investigation of transcription
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factor binding by DNA-protein cross linking studies (ChlP), show that ChREBP is a
transcription factor that binds to the E-box region in the G6PDH promoter and that this
binding increases within 6 hour of high glucose incubation. The binding of ChREBP
decreases after 12 and 18 hours of high glucose treatment compared to the 6 hours but is
still higher than binding under low glucose conditions (Figure 12).
ChREBP is found in the cytoplasm at low glucose levels. Similar to the
mechanism involved in yeast glucose signaling, under low glucose conditions, cAMP
induced protein kinases phosphorylate the serine (S196, S626) and threonine (T666)
residues of ChREBP. The phosphorylation of these residues results in the retention of
ChREBP in the cytoplasm where it is inactive. Under high glucose conditions,
dephosphorylation by protein phosphatase 2A (PP2A) helps in the nuclear translocation
of the ChREBP where it binds to ChoRE sequences in the promoter sequence of various
genes (Kawaguchi et al., 2001). PP2A is activated by xylylose-5-phosphate, an
intermediate in the pentose phosphate pathway. Mutation of serine (S196, S626) and
threonine (T666) residues showed that under high glucose conditions, ChREBP is still
translocated to the nucleus for binding to ChoRE of genes like L-PK and FAS indicating
that the dephosphorylation of serine and threonine residues in ChREBP is not the primary
event in the nuclear translocation of this protein and that additional events may be
involved in glucose activation of ChREBP (Tsatsos and Towle, 2006).
ChREBP functions as a dimer with a max like protein (Mlx). It has also been
shown by Stoeckman et al. that the ChoRE binding region of promoters for ACC, L-PK,
and S-14 requires the formation of these dimers for the glucose regulation of these genes
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(Stoeckman et al., 2004). The promoters in these genes have two perfect E-box
(CACGTG) motifs separated by 5 bp. In these genes glucose induces the formation of
heterotetramers (One ChREBP/One Mlx + One ChREBP/Mlx) between the two E-boxes
(Stoeckman et al., 2004). Mutation of either of the E-boxes in L-PK yielded a loss in
binding of ChREBP/Mlx to the oligonucleotides and also decreased glucose responses
(Ma et al., 2006). Interestingly, Stoeckman et al also showed that the ChREBP/Mlx
heterodimer was able to bind to oligonucleotides containing a single E-box motif within
the ACC and S-14 promoters. The experiments were conducted for 12 hour and 24 hours
of high glucose treatment and the binding of ChREBP to the single E-box decreased with
time (Stoeckman et al., 2004). This heterodimer binding to a single perfect E-box motif is
a unique mechanism as it is not functional in the promoter of either the ACC, L-PK or S14 genes in rat.
G6PDH promoter sequence has a single imperfect E-box and it is attractive to
speculate that a similar heterodimer may mediate the glucose induction of G6PDH or a
single E-Box motif in G6PDH may be the reason for decreased binding after 6 hours of
high glucose treatments. The glucose response at 12 and 24 hour of ACC, L-PK, and S14 decreased when the single perfect E-box oilgonucleotides was used compared to the
oligonucleotides with two E-boxes separated by 5 bp. Our studies show that high glucose
increases G6PDH mRNA and is maximal at 18 hours. The high glucose induced binding
of ChREBP to the E-box of G6PDH is maximal at 6 hours and decreases with time. The
presence of an imperfect E-box as compared to perfect E-boxes of well studied lipogenic
genes like L-PK, ACC and FAS suggests that there may be a transient binding of this
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protein to the E-box region of G6PDH and other proteins may also be necessary to
complete the induction of G6PDH under high glucose treatments. It is thus important to
study whether or not ChREBP binding at the earlier time periods also occurs as well as if
other proteins are needed.
From the results presented here, glucose increases the expression of G6PDH in a
concentration and time dependent manner. The transcriptional inhibitor studies confirmed
that regulation of G6PDH expression by glucose occurs at the transcriptional level. The
translational inhibitor studies suggest that high glucose induction of G6PDH requires on
going protein synthesis. The ChIP assay showed that ChREBP is a transcription factor
that binds to the promoter of G6PDH under 6 hours of high glucose treatment and this
binding decreased with time. Thus the translational inhibitor studies and the ChREBP
binding studies suggest that, probably, there are other transcription factors and/or co
activators that are responsible for high glucose induction of G6PDH. Further studies are
crucial to better understand the transcriptional regulation of this important enzyme.
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Appendix A
Putative transcription factors in the G6PDH promoter
by computer database analysis
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Protein

T00422 IRF-1
T00753 So1
T00843 Ttk 69K
T00691 Pit-1a
T00684 PEA3
T00391 H4TF-1
T00321 GCN4
T00759 So1
T00635 NP-Ill
Gut-enriched
Krueppel-like
factor
T00113 c-Ets-2
T00702 PU.1
T00036 AP-4
T01944 NF-ATp
T00196 DI
T00196 DI
c-Rel
T00590 NFkappas
T00196 DI
T00550 NFAT-1
T00550 NFAT-1
H6 homeodomain
HMX3/Nkx5.1
transcription factor
c-Rel
NF-Kap
Elk-1
T00111 c-Ets-1
T00111 c-Ets-1
c-Ets-1
T02786 RITA-1
T02246 AML1c
c-Ets-1(054)
Elk-1

Bases Sequence Recognized
BeginEnd
5
14
16
44
45
47
54
59
63
68-80
70
75
79
86
86
86
86-98
87

AAGTGA
GGGCAG
GCAGGAGC
TAGGAAATCT
AGGAAA
GAAATC
TAGTCA
AGGCGG
GGTCAC
GTGGGGTTTTCCA

CTTCCC
CTTCTC
YCAGCTGYGG
TGGAAAAC
GGGAAAACCC
GGGARAWMCM
GTGGGGTTTTCCA

92-106

GGAAATCCCC
GGAAAAACCC
GGAAAA
GGAAAA
AAGCCGAAGTGGGGT

91-99

AAAACCCCACTT

91-99

AAAACCCCACTT

96-116

ACGACACCGGAAGCCGAAGT

87
87
87

102
102
106-116
110
120
122-142
125

AGCTTCCGGT
TGCTTCCGGT
TTCCGGTGTCG
GTGACGTAAG
TGTGGG
TGGGATCCGGAAGTAAAACA
GGATCCGGAAGTAAAA
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Database/
Identifier

TESS
TESS
TESS
TESS
TESS
TESS
TESS
TESS
TESS
Mats Inspector
TESS
TESS
TESS
TESS
TESS
TESS
Mats Inspector
TESS
TESS
TESS
TESS
Mats Inspector
TFSearch
TFSearch
Mats Inspector
TESS
TESS
TFSearch
TESS
TESS
Mats Insoector
TFSearch

Protein

T00115 c-Ets-1
T01143 E1A-F
Winged-helix
transcription factor
IL-2
T00402 ICSBP

Bases Sequence Recognized
BeginEnd
128
129
130-146
131

T00851 T3R-beta

132

T00582 NF-IL-2A
T01530 corebindinQ

135

T00360 HiNF-A
T00918 Zeste
Gut-enriched
Krueppel-like
factor
Barx2, homeobox
transcription factor
T00802 TCF1alpha

134

CCGGAAGT
CGGAAGT
GGAAGTAAAACACAGAC

GAAGTGAAAC
AAGTAA
GTAAAAC

Database/
Identifier
TESS
TESS
Mats Inspector
TESS
TESSTESS

146-158

GACTCA
CTCAAAGGCATTA

TESS
TESS
TESS
Mats Inspector

146-162

GTATTAATGCCmGAG

Mats Inspector

CAAAGG

137
144

148

TAAACCACAG
AAACACA

155-169

TTAATACT
ATTAATACTAGAGAG

TESS
TFSearch
Mats Inspector

Myelin
transcription factor
1-like

164-176

AGAGAGTTAAAAC

MatsInspector

Myelin
transcription factor
1-like

164-176

AGAGAGTTAAAAC

Mats Inspector

Member of b-zip
family
HSF2

183-195

GTGCCACACTCTG

Mats Inspector

229-253

CAGCGGAACAGCAGAATGCTCCTTA

Mats Inspector

GAACAG

TESS
TESS
TESS
Mats Inspector

CdXA
Special AT-rich
sequence-binding
protein 1

T00475 LVa
T01085 abaA
T01085 abaA
GATA binding
. factor
T00267 GATA-1
T00305 GATA-1
T00267 GATA-1
T00333 GR

155-162

234
241
241
252-264
255
255
256
263

AGAATG
AGAATG
TACTGATAAACAT

TESS
TESS
TESS
TESS

TGATAA
TGATAA
GATAAA
ATCACA
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Protein

T00395 Hb
T00617 NF-Zz
T02786 RITA-1
T02786 RITA-1
Smad3
transcription
factor(TGF-beta
signaling)
T00918 Zeste

Bases Sequence Recognized
BeginEnd
285
299
304
304
311-319

328

332

T00311 GATA-3
MyoD/E47 and
MyoD/E12 dimers
USF

350
337-345

PTF1 binding
sites
HILZ
C/EBP

338 358
338-352
338-351

T00204 E12

338

T00524 MyoD
T00204 E12
T00003 AS-C T3
NMP4 (nuclear
matrix protein 4) /
CIZ protein
E2F, interacts with
Rb p107 protein
T00550 NFAT-1
T00550 NFAT-1
Homeodomain
transcription factor
Otx2
T01498 IL-6
T01469 lk-1
Bach2 bound TRE

Activator protein 1
Activator protein 1

334 -

340
340
340
345-355

346-362

350
350

357-373

TTAI111111
AGGGTCC
CCTACGTAGG
CCTACGTAGG
GTCTGGTCT

GACTCA

CAGATATCCA

AAAGGCAGGTGGATCTC

GATCCACCTG
TCCACCTGCCIIIllICCGTC

Database/
Identifier

TESS
TESS
TESS
TESS
Mats Inspector

TESS ·
TESS
Mats Inspector
TFSearch
Mats Inspector

GGAAAAAAGGC

TFSearch
Mats Inspector
TESS
TESS
TESS
TESS
Mats Inspector

AGTAGACGGAAAAAAGG

MatsInspector

TTTTCC

TESS
TESS
Mats Inspector

CACCTGCCTTTTT
CACCTGCCTTTTT
GCCACCTGCC
CACCTG
CACCTGC
CACCTG

TTTTCC
GCTTTAATCCCAGTAGA

367-391

TGGGATT
TTAAAGCAGTGAGTCACCATGTCCA

TESS
TESS
Mats Inspector

374-384

AGTGAGTCACC

Mats Inspector

374-384

GGTGACTCACT

Mats Inspector

361
362

CTGGGA
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Protein
T00029 AP-1
AP-1
T00918 Zeste
T00029 AP-1
T00321 GCN4
T00321 GCN4
T00517 myc-CF1
T00918 Zeste
Sterol regulatory
element binding
protein 1 and 2
T00137 c-Myb
Yin and Yang 1
repressor sites
T00076
CACbinding
T00278 delta
factor
T00395 Hb
MEL1
(MDS1/EVl1-like
gene 1) DNAbinding domain 2
Zinc finger
transcription
factor, Zic family
member 2
T00076
CACbinding
T00535 NF-1
T00759 Sp1
Spi1/transcription
factor PU.1
T00702 PU.1
T00759 Sp1
Ets - family
member ELF-2
(NERF1a)
Hypoxia inducible
factor, bHLH /
PAS protein family

Bases Sequence Recognized
BeginEnd

376
376-385
376
376
377
377
383
392
398 412
400
401-419
402
406
408

Database/
Identifier

CACTCG
CTCTCACCCCATTTT

TESS
TFSearch
TESS
TESS
TESS
TESS
TESS
TESS
Mats Inspector

CTCACC
TCACCCCATTTTCAAGGCA

TESS
Mats Inspector

TGAGTCA
AGTGAGTCACCAT
TGAGTC
TGAGTCA
GAGTCA
GAGTCA
CCATGT

TESS

CACCCC

TESS

CCATTT

417-433

TTTTTCAAGG
TAGTGAGGATGCGATGC

TESS
Mats Inspector

432-446

TAAAACACCCCTGGC

Mats Inspector

437
442
455
477-497
483

TESS

CACCCC
CTGGCT
GCCCGGCCCC
AGTCTAGAGGAAGCTGCGAA

TESS
TESS
Mats Inspector

519-539

GGCCCC
TAGCCTCAGGAAGGCGTGGC

TESS
TESS
Mats Inspector

534-546

GTGGCTACGTGCT

Mats Inspector

502

GAGGAA
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Protein

Bases Sequence Recognized
BeginEnd

Database/
Identifier

544-556

GCTAACGGAAGTG

544-550

GCTAACG

NRF

544-550

GCTAACG

NRF-2

546-550

AACG

546-560

TAACGGAAGTGGGGT

Mats Inspector
TFSearch
TFSearch
TFSearch
Mats Inspector

551-565

GGATGACCCCACTTC

Mats Inspector

557-568

GGTCATCCGGGA

v-Myb
v-Myb

H6 homeodomain
HMX3/Nkx5.1
transcription factor
Sterol regulatory
element binding
protein
Sterol regulatory
element binding
protein
T00029 AP-1

557

T00196 DI
T00719 RAR-

557

aloha1

Ribonucleoprotein
associated zinc
finger protein
Activator protein 2
alpha
Myelin
transcription factor
1-like,C2HC zinc
finqer factor 1
Zinc finger protein
transcriptional
repressor
T00368 HNF-1A

lkaros 1, potential
regulator of
lymphocyte
differentiation
Homeodomain
protein NKX3.2
ESP

E2F,interacts with
Rb p107 protein
transcriptional
repressor
(Kruppel-like
C2H2 zinc fingers)

557

GGGTCA
GGGTCATCCC

TFSearch
TESS
TESS
TESS

567-587

GGGTCA
GGAAGGTGCAGGGCCTTGGG

Mats Inspector

576-590

AGGGCCTTGGGGGCA

Mats Inspector

593-605

GGAAAGCTAGACC

Mats Inspector

614-626

TGGCTGGGGAGAC

Mats Inspector

614
626-638

TGGCTGG
CTAAGGGAATACA

TESS
Mats Inspector

641-655

AGAACTGAGTGGAGC

Mats Inspector

660-666

CCAATGC

724-740

AATGCGCGCGCAATCCC

TFSearch
Mats Inspector

724-736

GGGATTGCGCGCG

Mats Inspector
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Protein

Zinc finger/ POZ
domain
transcription factor
Zinc finger/ POZ
domain
transcription factor
Zinc finger/ POZ
domain
transcription factor
Zinc finger/ POZ
domain
transcription factor
GATA-binding
factor 10
T00305 GATA-1
T00305 GATA-1
T00267 GATA-1
Kidney-enriched
kruppel-like factor,
KLF15
Ecotropic viral
integration site 1
encoded factor
Kruppel-like zinc
finqer protein 219
Pleomorphic
adenoma gene
(PLAG) 1
Kruppel-like zinc
finqer protein 219
Kidney-enriched
kruppel-like factor,
KLF15
MYC-associated
zinc finqer protein
T00752 Sp1
Myeloid zinc
finger protein
MZF1
Purine-rich
element binding
protein A

Bases Sequence Recognized
BeginEnd

Database/
Identifier

727-737

GCGCGCGCAAT

Mats Inspector

728-738

TTGCGCGCGCA

Mats Inspector

729-739

ATGCGCGCGCA

Mats Inspector

730-740

GCGCGCGCATT

Mats Inspector

736-748

TAGAGATAAATGC

Mats Inspector

740

TESS
TESS
TESS

746-768

TTATCTCT
TTATCT
TTATCT
CTACTCTTCTCCCCCCCCTCCT

Mats Inspector

749-765

GAGGGGGGGGAGAAGAG

Mats Inspector

749-771

CTCTTCTCCCCCCCCTCCTCCC

Mats Inspector

752-772

GGGGGAGGAGGGGGGGGAG

Mats Inspector

752-774

TTCTCCCCCCCCTCCTCCCCCGC

Mats Inspector

753-769

GGAGGAGGGGGGGGAGA

Mats Inspector

753-765

GAGGGGGGGGAGA

Mats Inspector

740
740

753

TESS

753-761

TCTCCGCCCC
GGGGGGAGA

Mats Inspector

754-766

GGAGGGGGGGGAG

Mats Inspector
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Protein

Myc associated
zinc finger protein
(MAZ)
Collagen krox
protein (zinc finger
protein 67 - zfp67)
Zinc finger
transcription factor
ZBP-89
Myc associated
zinc finger protein
(MAZ)
T00759 Sp1
T00759 Sp1

Bases Sequence Recognized
BeginEnd

Database/
Identifier

757-769

GGAGGAGGGGGGG

Mats Inspector

758-774

GCGGGGGAGGAGGGGGG

Mats Inspector

758-780

CCCCCCTCCTCCCCCGCACTG

Mats Inspector

760-772

GGGGGAGGAGGGG

Mats Inspector

760
760

CCCCTCCCCC

TESS
TESS

Kidney-enriched
kruppel-like factor,
KLF15
Wilms Tumor
Suppressor
GATA binding
factor
GC box elements

761-777

CCCCTCC
AGTGCGGGGGAGGAGGG

Mats Inspector

762-778

CAGTGCGGGGGAGGAGG

Mats Inspector

774-786

CACTGATAGAGTA

Mats Inspector

792-806

AGCGGGGAGGAGCTT

Myeloid zinc
finger protein
MZF1
Elk protein

797-805

GCGGGGAGG

Mats Inspector
Mats Inspector

875-895

TAGCCCCCGGAAACGCTGTG

Mats Inspector

Binding site for a
Pbx1/Meis1
heterodimer

914-934

TTTAGTTGCCGCTGCCAAACA

Mats Inspector

T00599 NF-1/L

917

TESS

TTGGCA
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Appendix B
Protocol clearance from the institutional animal care and use committee
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